Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
c64bbc5383760f0690f12a20d9f4fb13fa76fe84836a4fd4c220e5c88f7d4003.png
complex
<table><tr><td>Activities</td><td>V1</td><td>V2</td><td>V3</td><td>V4</td><td>V5</td><td>V6</td><td>Recall (%)</td></tr><tr><td>V1</td><td>92</td><td>4</td><td>2</td><td>3</td><td>0</td><td>1</td><td>90.20</td></tr><tr><td>V2</td><td>1</td><td>27</td><td>0</td><td>0</td><td>0</td><td>0</td><td>96.43</td></tr><tr><td>V3</td><td>5</td><td>0</td><td>15</td><td>0</td><td>0</td><td>0</td><td>75.00</td></tr><tr><td>V4</td><td>5</td><td>0</td><td>0</td><td>105</td><td>2</td><td>2</td><td>95.45</td></tr><tr><td>V5</td><td>0</td><td>0</td><td>3</td><td>3</td><td>36</td><td>0</td><td>85.71</td></tr><tr><td>V6</td><td>0</td><td>0</td><td>1</td><td>1</td><td>0</td><td>16</td><td>88.89</td></tr><tr><td>Precision (%)</td><td>92.93</td><td>87.10</td><td>71.43</td><td>93.75</td><td>94.74</td><td>84.21</td><td></td></tr><tr><td>Accuracy (%)</td><td colspan="7">90.94</td></tr></table>
86c422f5c33f9da8e9b4a0c970b18a285580c5389e41ff2c0159f458ec3c2555.png
simple
<table><tr><td>Chromosome (potato)</td><td>Tomato</td><td>Citation<sup>1</sup></td></tr><tr><td>2</td><td>2 L inversion</td><td>a</td></tr><tr><td>3</td><td>Translocation</td><td>b</td></tr><tr><td>5</td><td>5S inversion</td><td>a, c, d, e, f</td></tr><tr><td>6</td><td>6S inversion</td><td>a, g</td></tr><tr><td>9</td><td>9S inversion</td><td>a, c, d, f</td></tr><tr><td>10</td><td>10 L inversion</td><td>a, c, d, f</td></tr><tr><td>11</td><td>11S inversion</td><td>a, c, f</td></tr><tr><td>12</td><td>12S inversion</td><td>a, c, f</td></tr></table>
8b34922a28d3886711a2583279be12498d0282798a10ce4c8d99aa35e3122b07.png
complex
<table><tr><td> </td><td colspan="7">Age group</td></tr><tr><td>Variables</td><td>G<sub>50-54</sub> n = 32</td><td>G<sub>55-59 </sub>n = 56</td><td>G<sub>60-64 </sub>n = 112</td><td>G<sub>65-69 </sub>n = 151</td><td>G<sub>70-74 </sub>n = 126</td><td>G<sub>75-79 </sub>n = 57</td><td>G<sub>80+ </sub>n = 22</td></tr><tr><td>Age, years</td><td>52.8 (1.3)</td><td>57.6 (1.6)</td><td>62.8 (1.5)</td><td>67.4 (1.4)</td><td>72.4 (1.4)</td><td>77.1 (1.4)</td><td>86.0 (4.3)</td></tr><tr><td>Height, m</td><td>1.537 (0.048)</td><td>1.542 (0.048)</td><td>1.515 (0.049)</td><td>1.502 (0.050)</td><td>1.495 (0.055)</td><td>1.471 (0.059)</td><td>1.429 (0.062)</td></tr><tr><td>Thigh length, m</td><td>0.350 (0.015)</td><td>0.351 (0.017)</td><td>0.343 (0.017)</td><td>0.341 (0.018)</td><td>0.342 (0.020)</td><td>0.336 (0.017)</td><td>0.332 (0.017)</td></tr><tr><td>Lower leg length, m</td><td>0.339 (0.018)</td><td>0.341 (0.017)</td><td>0.335 (0.017)</td><td>0.333 (0.017)</td><td>0.334 (0.018)</td><td>0.328 (0.016)</td><td>0.328 (0.015)</td></tr><tr><td>Body mass, kg</td><td>53.8 (6.1)</td><td>55.7 (7.2)</td><td>54.2 (6.5)</td><td>53.4 (6.9)</td><td>52.3 (6.9)</td><td>50.5 (6.7)</td><td>48.1 (6.6)</td></tr><tr><td>BMI, kg/m<sup>2</sup></td><td>22.8 (2.3)</td><td>23.5 (3.2)</td><td>23.7 (3.0)</td><td>23.7 (3.0)</td><td>23.4 (2.7)</td><td>23.3 (2.7)</td><td>23.6 (3.0)</td></tr></table>
4d4739132189b6a64f5dd07367e40fce5f85afc92c18106bf3d624a189fb62b6.png
complex
<table><tr><td>Buffer Radius (m)</td><td colspan="6">Number of children within buffer zone</td><td colspan="3">Comparison measures</td></tr><tr><td></td><td>Parcels</td><td>Street</td><td>Parcels yes/Street yes</td><td>Parcels yes/Street no</td><td>Parcel no/Street yes</td><td>Parcel no/Street no</td><td>Sensitivity (%)<sup>1</sup></td><td>Specificity (%)<sup>2</sup></td><td>Odds Ratio (95% CI)<sup>3</sup></td></tr><tr><td>50 meters</td><td>391</td><td>1413</td><td>151</td><td>240</td><td>1262</td><td>103212</td><td>39</td><td>99</td><td>0.28 (0.25 &#8211; 0.31)</td></tr><tr><td>100 meters</td><td>2090</td><td>2851</td><td>1392</td><td>698</td><td>1459</td><td>101316</td><td>67</td><td>99</td><td>0.73 (0.69 &#8211; 0.77)</td></tr><tr><td>150 meters</td><td>4717</td><td>5276</td><td>3899</td><td>818</td><td>1377</td><td>98771</td><td>83</td><td>99</td><td>0.89 (0.85 &#8211; 0.93)</td></tr><tr><td>250 meters</td><td>10729</td><td>10945</td><td>9704</td><td>1025</td><td>1241</td><td>92895</td><td>90</td><td>99</td><td>0.98 (0.95 &#8211; 1.01)</td></tr><tr><td>500 meters</td><td>26347</td><td>26597</td><td>25201</td><td>1146</td><td>1396</td><td>77122</td><td>96</td><td>98</td><td>0.99 (0.97 &#8211; 1.01)</td></tr><tr><td>1000 meters</td><td>54500</td><td>54614</td><td>53838</td><td>662</td><td>776</td><td>49589</td><td>99</td><td>98</td><td>01.00 (0.980 &#8211; 1.01)</td></tr></table>
a44d998e832ae56bb388847ec730cb1d2110cffb0ce84ab7f08ed64c0a2eb894.png
complex
<table><tr><td></td><td></td><td colspan="2">Model I</td><td colspan="2">Model II</td></tr><tr><td>Variable</td><td>Category</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td></tr><tr><td><i>Fixed effects</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><i>Rate of change</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Agec (Int)</td><td>Centred at 67 years</td><td>0.93</td><td>0.90-0.97</td><td>0.98</td><td>0.96-1.012</td></tr><tr><td>Agec*cohortc</td><td></td><td>1.017</td><td>1.011-1.024</td><td>1.009</td><td>1.006-1.011</td></tr><tr><td>Agec-squared</td><td></td><td>1.005</td><td>1.001-1.010</td><td>1.005</td><td>1.001-1.010</td></tr><tr><td><i>Initial status</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cohortc</td><td>Centred at 1924</td><td>0.98</td><td>0.95-1.02</td><td>1.02</td><td>1.00-1.05</td></tr><tr><td>Cohortc-squared</td><td></td><td>1.008</td><td>1.005-1.012</td><td>1.005</td><td>1.003-1.006</td></tr><tr><td rowspan="2">Educational level</td><td>Low-middle</td><td></td><td></td><td>1</td><td></td></tr><tr><td>High</td><td></td><td></td><td>1.23</td><td>0.96-1.58</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>Centred at 23</td><td></td><td></td><td>0.93</td><td>0.91-0.96</td></tr><tr><td rowspan="3">Smoking</td><td>Never</td><td></td><td></td><td>1</td><td></td></tr><tr><td>Former</td><td></td><td></td><td>1.01</td><td>0.78-1.30</td></tr><tr><td>Daily</td><td></td><td></td><td>0.48</td><td>0.35-0.65</td></tr><tr><td rowspan="2">Self-reported health status</td><td>Good</td><td></td><td></td><td>2.57</td><td>2.08-3.19</td></tr><tr><td>Poor</td><td></td><td></td><td>1</td><td></td></tr><tr><td colspan="2"><i>Random effects (unstructured)</i></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="2">Var (constant)</td><td>1.51</td><td>1.01-2.23</td><td>1.05</td><td>0.66-1.69</td></tr></table>
0d2295d6342b67526023ac936bb8dcb5e126aa2b535dcf2dbc9fead880d7e069.png
complex
<table><tr><td></td><td colspan="3">Assay 1(Quantitect, 2 min A&amp;E)<underline>Primer Pairs</underline></td><td colspan="3">Assay 2(Quantifast, 1 min A&amp;E)<underline>Primer Pairs</underline></td></tr><tr><td>Tree number (genotype)</td><td>T1-C2</td><td>G1-A2</td><td>G1-C2</td><td>T1-C2</td><td>G1-A2</td><td>G1-C2</td></tr><tr><td>Tree-14 (G-T/G-G)</td><td>1100</td><td>16000</td><td>18000</td><td>17000</td><td>53000</td><td>47000</td></tr><tr><td>Tree-17 (G-T/G-G)</td><td>1400</td><td>23000</td><td>29000</td><td>22000</td><td>54000</td><td>31000</td></tr><tr><td>Tree -20 (G-T/G-G)</td><td>1500</td><td>32000</td><td>21000</td><td>30000</td><td>81000</td><td>74000</td></tr><tr><td>Mean &#177; SD</td><td>1400 &#177; 200</td><td>24000 &#177; 8000</td><td>23000 &#177; 6000</td><td>23000 &#177; 7000</td><td>63000 &#177; 16000</td><td>51000 &#177; 22000</td></tr><tr><td>Tree-2 (G-T/G-T)</td><td>18</td><td>24000</td><td>380</td><td>11000</td><td>27000</td><td>20000</td></tr><tr><td>Tree-4 (G-T/G-T)</td><td>67</td><td>51000</td><td>1100</td><td>15000</td><td>35000</td><td>25000</td></tr><tr><td>Tree-6 (G-T/G-T)</td><td>69</td><td>54000</td><td>630</td><td>23000</td><td>60000</td><td>47000</td></tr><tr><td>Mean &#177; SD</td><td>51 &#177; 29</td><td>43000 &#177; 16000</td><td>690 &#177; 30</td><td>17000 &#177; 6000</td><td>41000 &#177; 17000</td><td>31000 &#177; 14000</td></tr></table>
3a8dc09e8d3f319376c0c17fd84c289248811ff9ab06fadde32aa44a0d4fc2dc.png
complex
<table><tr><td>Exon</td><td>Mutation</td><td>Base change</td><td>Amino acid change</td><td>Mutated samples</td><td>%</td></tr><tr><td><i>BRAF</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td rowspan="2">15</td><td rowspan="2">V600E</td><td>1799</td><td rowspan="2">Val to Glu</td><td rowspan="2">347</td><td rowspan="2">92.3</td></tr><tr><td>T &gt; A</td></tr><tr><td>15</td><td>V600K</td><td>1798-99 GT &gt; AA</td><td>Val to Lys</td><td>20</td><td>5.3</td></tr><tr><td rowspan="2">15</td><td rowspan="2">V600D</td><td>1799-1800</td><td rowspan="2">Val to Asp</td><td rowspan="2">6</td><td rowspan="2">1.6</td></tr><tr><td>TG &gt; AT</td></tr><tr><td rowspan="2">15</td><td rowspan="2">V600R</td><td>1798-99</td><td rowspan="2">Val to Arg</td><td rowspan="2">2</td><td rowspan="2">0.5</td></tr><tr><td>GT &gt; AG</td></tr><tr><td rowspan="2">15</td><td rowspan="2">L597R</td><td>1790</td><td rowspan="2">Leu to Arg</td><td rowspan="2">1</td><td rowspan="2">0.3</td></tr><tr><td>T &gt; G</td></tr><tr><td><i>NRAS</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td rowspan="2">3</td><td rowspan="2">Q61R</td><td>182</td><td rowspan="2">Gln to Arg</td><td rowspan="2">47</td><td rowspan="2">58.8</td></tr><tr><td>A &gt; G</td></tr><tr><td rowspan="2">3</td><td rowspan="2">Q61L</td><td>182</td><td rowspan="2">Gln to Leu</td><td rowspan="2">23</td><td rowspan="2">28.7</td></tr><tr><td>A &gt; T</td></tr><tr><td rowspan="2">3</td><td rowspan="2">Q61K</td><td>181</td><td rowspan="2">Gln to Lys</td><td rowspan="2">10</td><td rowspan="2">12.5</td></tr><tr><td>C &gt; A</td></tr></table>
8d3eb6e50e35f3e0edbe1796c200e4eaaef85b8f48618f69310871e2aa9d571a.png
simple
<table><tr><td></td><td>January</td><td>February</td><td>March</td><td>April</td><td>May</td><td>June</td><td>July</td><td>August</td><td>September</td><td>October</td><td>November</td><td>December</td></tr><tr><td> Number of sirocco days</td><td>0</td><td>0</td><td>0</td><td>3</td><td>26</td><td>59</td><td>111</td><td>53</td><td>11</td><td>0</td><td>0</td><td>0</td></tr></table>
c703e8e40451f8725a29c3910b5f915a240f423474b1dee4fd6e304ade666aa0.png
complex
<table><tr><td rowspan="3">Biochemical parameters</td><td colspan="2">Control groups</td><td colspan="3">Treated groups</td></tr><tr><td>absolute</td><td>relative</td><td>Day 1</td><td>Day 7</td><td>Day 14</td></tr><tr><td>Glucose (mg dl-1)</td><td>125.0 &#177; 11.4</td><td>119.0 &#177; 19.5</td><td>122.0 &#177; 20.9</td><td>121.0 &#177; 18.0</td><td>118.0 &#177; 18.0</td></tr><tr><td>Urea (mg dl-1)</td><td>29.6 &#177; 3.5</td><td>30.8 &#177; 4.2</td><td>29.2 &#177; 1.8</td><td>30.7 &#177; 4.1</td><td>32.3 &#177; 3.6</td></tr><tr><td>Creatinine (mg dl-1)</td><td>0.33 &#177; 0.06</td><td>0.38 &#177; 0.15</td><td>0.38 &#177; 0.06</td><td>0.35 &#177; 0.13</td><td>0.39 &#177; 0.05</td></tr><tr><td>Triglyceride (mg dl-1)</td><td>76.0 &#177; 6.2</td><td>74.0 &#177; 5.8</td><td>73.0 &#177; 5.7</td><td>74.0 &#177; 5.6</td><td>74.0 &#177; 5.9</td></tr><tr><td>Total cholesterol (mg dl-1)</td><td>60.8 &#177; 6.3</td><td>57.2 &#177; 8.2</td><td>56.9 &#177; 5.6</td><td>57.9 &#177; 8.1</td><td>56.5 &#177; 6.5</td></tr><tr><td>Uric acid (mg dl-1)</td><td>0.53 &#177; 0.10</td><td>0.53 &#177; 0.08</td><td>0.49 &#177; 0.10</td><td>0.53 &#177; 0.10</td><td>0.52 &#177; 0.07</td></tr><tr><td>Albumin (g dl-1)</td><td>2.8 &#177; 0.3</td><td>2.7 &#177; 0.4</td><td>2.6 &#177; 0.3</td><td>2.9 &#177; 0.3</td><td>2.8 &#177; 0.3</td></tr><tr><td>Alkaline phosphatase (Units)</td><td>50.6 &#177; 8.3</td><td>51.9 &#177; 8.0</td><td>52.8 &#177; 8.6</td><td>49.5 &#177; 7.6</td><td>47.4 &#177; 7.5</td></tr><tr><td>ALT (Units)</td><td>130 &#177; 10.3</td><td>122 &#177; 9.6</td><td>123 &#177; 8.7</td><td>128 &#177; 8.9</td><td>123 &#177; 6.1</td></tr><tr><td>AST (Units)</td><td>74 &#177; 6.0</td><td>73 &#177; 5.9</td><td>76 &#177; 6.8</td><td>73 &#177; 5.9</td><td>75 &#177; 6.9</td></tr></table>
54a05d11366549334c6f44ccfda4b3c10eba020d302b3fdcdecbcc9cfcb09756.png
simple
<table><tr><td>Movement of Households</td><td>Wealth index (PCA)</td><td>Consumption Expenditure</td></tr><tr><td>Proportion of households ranked in the same tercile</td><td>60.99</td><td>42.64</td></tr><tr><td>Proportion of households moving by one tercile</td><td>32.18</td><td>34.93</td></tr><tr><td>Proportion of households moving by two terciles</td><td>6.83</td><td>22.43</td></tr><tr><td>Kappa statistic</td><td>0.373***</td><td>0.122***</td></tr></table>
75310de40e8d6d691a17136a5b81e84b9c38bee0c53bad40daf9d8b3b9c1666d.png
complex
<table><tr><td>InterPro entry</td><td>Signatures</td><td>Analysis method</td></tr><tr><td rowspan="4">IPR000043 (Family)</td><td>TIGR00936 (ahcY)</td><td>HMMTigr</td></tr><tr><td>PF05221 (AdoHcyase)</td><td>HMMPfam</td></tr><tr><td>PTHR23420 (Ad_hcy_hydrolase)</td><td>HMMPanther</td></tr><tr><td>PIRSF001109 (Ad_hcy_hydrolase)</td><td>HMMPIR</td></tr><tr><td>IPR015878 (Domain)</td><td>PF00670 (AdoHcyase_NAD)</td><td>HMMPfam</td></tr><tr><td rowspan="2">IPR020082 (Site)</td><td>PS00738 (ADOHCYASE_1)</td><td>PatternScan</td></tr><tr><td>PS00739 (ADOHCYASE_2)</td><td>PatternScan</td></tr></table>
a223cd80bf53dd9841676e35b92db6c0537745ebb5d90359f6784ecf34bc4ad9.png
complex
<table><tr><td rowspan="2">Exposure</td><td colspan="3">Mean difference in gestational age acceleration (days)</td></tr><tr><td>Mean difference</td><td>95% CI</td><td><i>p</i></td></tr><tr><td>Female</td><td>&#8722; 0.8</td><td>&#8722; 1.4, &#8722; 0.1</td><td>0.024</td></tr><tr><td>High/non-manual parental social class</td><td>0.1</td><td>&#8722; 0.9, 1.0</td><td>0.91</td></tr><tr><td colspan="4">Maternal education</td></tr><tr><td> Degree</td><td>(Ref)</td><td></td><td>0.72</td></tr><tr><td> A level</td><td>0.8</td><td>&#8722; 0.1, 1.8</td><td></td></tr><tr><td> O level</td><td>&#8722; 0.1</td><td>&#8722; 1.0, 0.8</td><td></td></tr><tr><td> Less than O level</td><td>&#8722; 0.3</td><td>&#8722; 1.4, 0.8</td><td></td></tr><tr><td colspan="4">Paternal education</td></tr><tr><td> Degree</td><td>(Ref)</td><td></td><td>0.51</td></tr><tr><td> A level</td><td>&#8722; 0.8</td><td>&#8722; 1.6, 0.1</td><td></td></tr><tr><td> O level</td><td>&#8722; 0.2</td><td>&#8722; 1.2, 0.7</td><td></td></tr><tr><td> Less than O level</td><td>0.3</td><td>&#8722; 0.7, 1.2</td><td></td></tr><tr><td colspan="4">Housing tenure</td></tr><tr><td> Owned/mortgaged</td><td>(Ref)</td><td></td><td>0.42</td></tr><tr><td> Rented (private)</td><td>0.7</td><td>&#8722; 1.1, 2.5</td><td></td></tr><tr><td> Rented (council/HA)</td><td>0.2</td><td>&#8722; 1.1, 1.5</td><td></td></tr><tr><td colspan="4">Financial difficulties</td></tr><tr><td> None</td><td>(Ref)</td><td></td><td>0.55</td></tr><tr><td> Some</td><td>&#8722; 0.1</td><td>&#8722; 0.8, 0.6</td><td></td></tr><tr><td> Many</td><td>&#8722; 0.4</td><td>&#8722; 1.3, 0.6</td><td></td></tr></table>
b9e816ea8f5bd15ebd370d6709b79b12eb3001ac1897e13fdf7ab4143d5c2970.png
simple
<table><tr><td>Component Label</td><td>Component</td><td>Subsystem function</td><td>Enjoyment of negative emotion example</td></tr><tr><td>1. Appraisal</td><td>Cognitive component</td><td>Evaluation of objects and events</td><td>Context detection/knowledge (music, aesthetic)</td></tr><tr><td>2. Bodily symptoms</td><td>Neurophysiological component</td><td>System regulation</td><td>Bodily symptoms of the negative emotion</td></tr><tr><td>3. Action tendencies</td><td>Motivational component</td><td>Preparation and direction of action</td><td>Inhibition of aversion/hostility tendencies</td></tr><tr><td>4. Facial and vocal expression</td><td>Motor expression component</td><td>Communication of reaction and behavioral intention</td><td>Facial symptoms of the negative emotion</td></tr><tr><td>5. Emotional experience</td><td>Subjective feeling component</td><td>Monitoring or internal state and organism-environment interaction</td><td>Subjective feeling of the negative emotion (fully fledged, real negative emotion)</td></tr></table>
4bc4890ff7374e5a078d1a45cde73181676e38f4b84beb658d7b9a54cc4320bb.png
complex
<table><tr><td colspan="2"> Domains</td><td> Average (&#177; standard deviation)</td></tr><tr><td colspan="2"> HAT-QoL (n= 201)</td><td></td></tr><tr><td></td><td> Overall function</td><td> 79.39 (20.9)</td></tr><tr><td></td><td> Life satisfaction</td><td> 71.9 (24.4)</td></tr><tr><td></td><td> Health worries</td><td> 83.2 (22.9)</td></tr><tr><td></td><td> Financial worries</td><td> 55.6 (37.5)</td></tr><tr><td></td><td> Medication worries</td><td> 88.7 (17.3)</td></tr><tr><td></td><td> HIV mastery</td><td> 77.8 (33.6)</td></tr><tr><td></td><td> Disclosure worries</td><td> 39.0 (27.3) </td></tr><tr><td></td><td> Provider trust</td><td> 72.2 (30.7)</td></tr><tr><td></td><td> Sexual function</td><td> 45.9 (43.5) </td></tr><tr><td colspan="2"> ASKAS</td><td></td></tr><tr><td></td><td> Knowledge </td><td> 31.7 (6.7)</td></tr><tr><td></td><td> Attitude</td><td> 14.8 (6.8)</td></tr></table>
2b710504152cf7b48804ddb17975da8f64b186fa53bee700eafed48c6b372e62.png
simple
<table><tr><td></td><td>Sha_w</td><td>Sha_15</td><td>BF_18</td><td>BF_22</td><td>ADGw_14</td><td>ADG14_22</td></tr><tr><td>Sha_w</td><td>0.04 &#177; 0.04</td><td>&#8211;</td><td>0.05 &#177; 0.03</td><td>0.06 &#177; 0.03</td><td>0.04 &#177; 0.03</td><td>0.07 &#177; 0.03</td></tr><tr><td>Sha_15</td><td>&#8211;</td><td>0.18 &#177; 0.08</td><td>&#8722; 0.10 &#177; 0.03</td><td>&#8722; 0.08 &#177; 0.03</td><td>&#8722; 0.09 &#177; 0.03</td><td>&#8722; 0.09 &#177; 0.03</td></tr><tr><td>BF_18</td><td>0.42 &#177; 0.50</td><td>&#8722; 0.53 &#177; 0.23</td><td>0.30 &#177; 0.11</td><td>&#8211;</td><td>0.43 &#177; 0.03</td><td>0.31 &#177; 0.03</td></tr><tr><td>BF_22</td><td>0.52 &#177; 0.49</td><td>&#8722; 0.45 &#177; 0.25</td><td>&#8211;</td><td>0.28 &#177; 0.10</td><td>&#8211;</td><td>0.45 &#177; 0.03</td></tr><tr><td>ADGw_14</td><td>&#8722; 0.73 &#177; 0.51</td><td>&#8722; 0.53 &#177; 0.32</td><td>0.29 &#177; 0.32</td><td>&#8211;</td><td>0.09 &#177; 0.06</td><td>&#8211;</td></tr><tr><td>ADG14_22</td><td>0.44 &#177; 0.48</td><td>&#8722; 0.53 &#177; 0.29</td><td>0.10 &#177; 0.29</td><td>0.24 &#177; 0.28</td><td>&#8211;</td><td>0.17 &#177; 0.08</td></tr></table>
ad38f0cb753294910ef67e27e48b1148671d5db428cfb856da062cad5a3b4650.png
simple
<table><tr><td>Gene</td><td>GenBank</td><td>Forward primer</td><td>Reverse primer</td><td>Amplicon</td></tr><tr><td>Name</td><td>Accession</td><td>5&#8242; &#8594; 3&#8242;</td><td>5&#8242; &#8594; 3&#8242;</td><td>Size (bp)</td></tr><tr><td>CD25</td><td>NM_174358</td><td>AGATGTCCTGGCTTGAAC</td><td>TGGATATAGACCTGCTAATACC</td><td>134</td></tr><tr><td>CCNA1</td><td>XM_005687507</td><td>CGCCACATTTACAGGCTATTCATT</td><td>GTACTTCTCCCTGATTGCTTGCTG</td><td>112</td></tr><tr><td>CCNB1</td><td>XM_005694606</td><td>TTGATGGAACTGACTATGCTGGACT</td><td>CAGGTAATGCTGTAGAGTTGGTGTC</td><td>132</td></tr><tr><td>CCND1</td><td>XM_005700049</td><td>AGGAGGTGAGGGTGGAAGTGTG</td><td>GAAGTCATCGGTAGCAGCGAATAA</td><td>100</td></tr><tr><td>GAPDH</td><td>DQ152956</td><td>CCTGGAGAAACCTGCCAAGT</td><td>GCCAAATTCATTGTCGTACCA</td><td>200</td></tr></table>
a61ed153af04aa56ee50a96ea6437a1e598b9a0feae6bbf2dfc2096a7e2ccf6a.png
simple
<table><tr><td>Software</td><td>Normal</td><td>Truncated</td><td>Solo-LTR</td><td>Complex</td><td>Nested</td><td>Total</td></tr><tr><td>LTRtype</td><td>59</td><td>200</td><td>172</td><td>7</td><td>182</td><td>438</td></tr><tr><td>REannotate</td><td>64</td><td>401</td><td>115</td><td>0</td><td>230</td><td>580</td></tr><tr><td>TEnest</td><td>49</td><td>281</td><td>119</td><td>0</td><td>427</td><td>449</td></tr></table>
199ea90fe4a77ba724b33d42575768ace715f7e0ada719c8873a404cfc15cabb.png
simple
<table><tr><td>Diagnostic Group</td><td>Number (men/women)</td><td>Age at Symptom Onset*</td><td>Age at PET Scan*</td><td>MMSE Score (max = 30)<sup>+</sup></td><td>Disease Duration (years)*</td></tr><tr><td>Cohort</td><td>102 (55/47)</td><td>60.06 (4.28)</td><td>64.04 (8.90)</td><td>25 (5&#8211;30)</td><td>5.74 (2.75)</td></tr><tr><td>AD</td><td>49 (24/25)</td><td>61.75 (9.73)</td><td>65.65 (9.41)</td><td>20.97 (5.10)</td><td>5.34 (2.08)</td></tr><tr><td>FTD</td><td>17 (10/7)</td><td>59.87 (6.72)</td><td>63.42 (7.80)</td><td>25.44 (3.32)</td><td>5.19 (2.27)</td></tr><tr><td>DLB</td><td>6 (6/0)</td><td>64.47 (5.13)</td><td>69.19 (4.65)</td><td>27.40 (1.82)</td><td>6.68 (2.85)</td></tr><tr><td>PPA</td><td>6 (3/3)</td><td>61.18 (8.66)</td><td>67.54 (7.59)</td><td>21.00 (10.65)</td><td>7.28 (3.37)</td></tr><tr><td>Depress</td><td>11 (6/5)</td><td>53.02 (8.28)</td><td>56.29 (7.92)</td><td>27.11 (2.89)</td><td>5.34 (1.85)</td></tr></table>
f588294c245ec0e388f74809e78d512731a8aa3f72ad6b6ba33ae42abaddc7b3.png
complex
<table><tr><td>Serotype</td><td>All</td><td colspan="2">Fatal outcome</td><td colspan="2">Any risk factor</td><td colspan="2">Pneumonia</td><td colspan="2">Meningitis</td></tr><tr><td> </td><td>No</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value</td></tr><tr><td> </td><td>Children</td><td>(all = 95)</td><td> </td><td>(all = 95)</td><td> </td><td>(all = 93)</td><td> </td><td>(all = 93)</td><td> </td></tr><tr><td><i>1</i></td><td><i>10</i></td><td>0 (0%)</td><td>ns</td><td>2 (22%)</td><td>ns</td><td>7 (88%)</td><td>0.007</td><td>0 (0%)</td><td>ns</td></tr><tr><td><i>5</i></td><td><i>6</i></td><td>0 (0%)</td><td>ns</td><td>0 (0%)</td><td>ns (0.059)</td><td>2 (40%)</td><td>ns</td><td>3 (60%)</td><td>ns (0.084)</td></tr><tr><td><i>19 F</i></td><td><i>11</i></td><td>2 (18%)</td><td>ns</td><td>5 (46%)</td><td>ns</td><td>5 (46%)</td><td>ns</td><td>2 (18%)</td><td>ns</td></tr><tr><td><i>6B</i></td><td><i>8</i></td><td>2 (25%)</td><td>ns</td><td>4 (50%)</td><td>ns</td><td>2 (25%)</td><td>ns</td><td>3 (38%)</td><td>ns</td></tr><tr><td><i>14</i></td><td><i>14</i></td><td>0 (0%)</td><td>ns</td><td>5 (36%)</td><td>ns</td><td>4 (31%)</td><td>ns</td><td>3 (23%)</td><td>ns</td></tr><tr><td>All serotypes</td><td> </td><td>12 (13%)</td><td> </td><td>44 (46%)</td><td> </td><td>38 (41%)</td><td> </td><td>22 (24%)</td><td> </td></tr><tr><td> </td><td>Adults</td><td>(all = 138)</td><td> </td><td>(all = 138)</td><td> </td><td>(all = 136)</td><td> </td><td>(all = 136)</td><td> </td></tr><tr><td><i>1</i></td><td><i>24</i></td><td>3 (13.0%)</td><td>ns</td><td>10 (43.5%)</td><td>&lt;0.001</td><td>20 (87.0%)</td><td>&lt;0.001</td><td>2 (8.7%)</td><td>0.038</td></tr><tr><td><i>5</i></td><td><i>16</i></td><td>4 (25.0%)</td><td>ns</td><td>11 (68.8%)</td><td>ns</td><td>9 (64.3%)</td><td>ns</td><td>2 (14.3%)</td><td>ns</td></tr><tr><td><i>19 F</i></td><td><i>7</i></td><td>2 (40.0%)</td><td>ns</td><td>6 (100%)</td><td>ns</td><td>3 (60.0%)</td><td>ns</td><td>2 (40.0%)</td><td>ns</td></tr><tr><td><i>6B</i></td><td><i>10</i></td><td>3 (30.0%)</td><td>ns</td><td>10 (100.0%)</td><td>ns</td><td>2 (20.0%)</td><td>ns</td><td>6 (60.0%)</td><td>0.022</td></tr><tr><td><i>14</i></td><td><i>3</i></td><td>1 (33.3%)</td><td>ns</td><td>2 (66.7%)</td><td>ns</td><td>3 (100.0%)</td><td>ns</td><td>0 (0%)</td><td>ns</td></tr><tr><td>All serotypes</td><td> </td><td>37 (26.8%)</td><td> </td><td>107 (77.5%)</td><td> </td><td>64 (47.1%)</td><td> </td><td>36 (26.5%)</td><td> </td></tr></table>
2cf86b43f16cd78c038b7033bc52a5961510c3ff67a37fad5a8a524e27f571a2.png
simple
<table><tr><td>Age</td><td><i>n</i></td><td>Total number ofCPECs counted</td><td>PP+ve CPECs</td><td>BrdU+ve CPECs</td><td>PP/BrdUdouble-labelled CPECs(<i>n </i>= 4)</td></tr><tr><td>P3</td><td>6</td><td>1855 &#177; 260</td><td>131 &#177; 36</td><td>44 &#177; 3</td><td>0</td></tr><tr><td>P4</td><td>6</td><td>2060 &#177; 125</td><td>175 &#177; 12</td><td>59 &#177; 7</td><td>2 &#177; 1</td></tr><tr><td>P5</td><td>6</td><td>2675 &#177; 205</td><td>216 &#177; 33</td><td>76 &#177; 12</td><td>6 &#177; 2</td></tr><tr><td>P10</td><td>6</td><td>3254 &#177; 106</td><td>230 &#177; 45</td><td>65 &#177; 17</td><td>11 &#177; 2</td></tr><tr><td>P30</td><td>6</td><td>7790 &#177; 928</td><td>695 &#177; 113</td><td>71 &#177; 10</td><td>-</td></tr><tr><td>P45</td><td>6</td><td>11104 &#177; 874</td><td>512 &#177; 84</td><td>80 &#177; 16</td><td>24 &#177; 4</td></tr><tr><td>P65</td><td>6</td><td>12175 &#177; 954</td><td>502 &#177; 54</td><td>63 &#177; 7</td><td>39 &#177; 2</td></tr><tr><td><i>p value *</i></td><td></td><td>&lt; 0.05</td><td>&lt; 0.05</td><td>&lt; 0.05</td><td>&lt; 0.05</td></tr></table>
459fa140895f04397c6042a5e405767b4dd3478fa03c6a2ed06c2b0d11e8d61a.png
simple
<table><tr><td>Operational challenge</td><td>Description</td></tr><tr><td>High workload</td><td>- One of the major concerns was that the increased utilisation has put so much pressure on the limited medical staff in the facilities. There is large health worker-patient ratio and this affects the provision of responsive care.</td></tr><tr><td> </td><td>- Inadequate numbers of health staff was mentioned as a key cause of long waiting hours.</td></tr><tr><td> </td><td>- The absence of people with professional knowledge of claims processing and management.</td></tr><tr><td>Logistics/equipment</td><td>- Lack of ambulance for referrals especially on emergency cases.</td></tr><tr><td> </td><td>- Lack of sophisticated surgical equipments to reduce referrals of cases to the regional hospitals.</td></tr><tr><td> </td><td>- Inadequate medical equipments.</td></tr><tr><td> </td><td>- The absence of operating theatres in the facilities to cope with new and emerging diseases.</td></tr><tr><td>Medication</td><td>- Many of the complaints related to the fact that the Essential Drug List (EDL) does not adequately cover a wide range of drugs. It is therefore difficult for patients to comprehend why they are not entitled to unlimited drugs under the scheme.</td></tr><tr><td>Networking</td><td>- Networking is a problem. As a result, some patients present expired ID cards with valid dates on them for treatment.</td></tr><tr><td> </td><td>- The absence of effective networking system makes activities of hospitals more difficult.</td></tr><tr><td> </td><td>- Because the system is not properly networked, there were instances when unregistered members scan their passport size pictures on ID cards of active members in order to receive medical care.</td></tr></table>
8b1e1ddfa550ecde33b09f99eb9d2258ce39dfd576eb3d9a6c0ac14e702d9946.png
complex
<table><tr><td rowspan="3">Wound dressing material</td><td colspan="2">Mean value &#177; standard error of the mean</td></tr><tr><td colspan="2">(number of vessels per high-power field)</td></tr><tr><td>The 7th postoperative day</td><td>The 10th postoperative day</td></tr><tr><td>Human amniotic membrane</td><td>0.90 &#177; 0.18</td><td>1.05 &#177; 0.14</td></tr><tr><td>Polyurethane foil</td><td>1.80 &#177; 0.16</td><td>4.70 &#177; 0.47</td></tr></table>
b7c760b1cb916d81cdc5dc4c623eccf15bd0657e0920015d13e78c257d2e535a.png
simple
<table><tr><td>Group</td><td>Articles, n</td><td>Studies, n</td><td>Sensitivity (95% ci),%</td><td>Specificity (95% ci),%</td></tr><tr><td>All data</td><td>103</td><td>132</td><td>70.8 (68.3-73.2)</td><td>95.8 (94.9-96.6)</td></tr><tr><td>Effect of STARD score</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>High quality score</td><td>53</td><td>73</td><td>70.9 (67.5-74.1)</td><td>95.7 (94.4-96.7)</td></tr><tr><td>Low quality score</td><td>50</td><td>59</td><td>70.7 (67.0-74.1)</td><td>96.0 (94.8-97.0)</td></tr><tr><td>Effect of STARD item 2</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>101</td><td>129</td><td>70.8 (68.3-73.2)</td><td>95.8 (94.9-96.6)</td></tr><tr><td>No<sup>&#165;</sup></td><td>2</td><td>3</td><td>NA</td><td>NA</td></tr><tr><td>Effect of STARD item 5</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>77</td><td>99</td><td>71.8 (69.0-74.5)</td><td>95.6 (94.5-96.5)</td></tr><tr><td>No</td><td>26</td><td>33</td><td>67.7 (62.6-72.4)</td><td>96.3 (94.9-97.4)</td></tr><tr><td>Effect of STARD item 7</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>80</td><td>103</td><td>71.0 (68.2-73.7)</td><td>95.9 (94.9-96.7)</td></tr><tr><td>No</td><td>23</td><td>29</td><td>70.0 (64.7-74.9)</td><td>95.6 (93.2-97.2)</td></tr><tr><td>Effect of STARD item 10</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>93</td><td>121</td><td>70.2 (67.5-72.7)*</td><td>95.9 (95.0-96.7)</td></tr><tr><td>No</td><td>10</td><td>11</td><td>77.5 (71.7-82.3)</td><td>94.5 (91.7-96.4)</td></tr><tr><td>Effect of STARD item 13</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>90</td><td>116</td><td>71.5 (68.9-74.1)**</td><td>95.6 (94.6-96.4)*</td></tr><tr><td>No</td><td>13</td><td>16</td><td>65.7 (59.7-71.2)</td><td>97.2 (96.2-97.9)</td></tr><tr><td>Effect of STARD item 16</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>55</td><td>66</td><td>73.3 (69.8-76.6)</td><td>94.6 (93.2-95.8)*</td></tr><tr><td>No</td><td>48</td><td>66</td><td>68.3 (64.9-71.5)</td><td>96.8 (95.7-97.7)</td></tr><tr><td>Effect of STARD item 19</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>77</td><td>105</td><td>70.5 (67.8-73.1)</td><td>95.8 (94.8-96.5)</td></tr><tr><td>No</td><td>26</td><td>27</td><td>72.3 (66.1-77.8)</td><td>96.4 (93.8-97.9)</td></tr></table>
f1fee9145939dd993fd143836e13e41056e72a8dbe6f9f5c7d12caf00fbc4627.png
simple
<table><tr><td>Property</td><td>Description</td><td>Encoding</td></tr><tr><td>TF_Class</td><td>Encoded 2&#8211;3 top levels of five digit code based on TFClass classification; i.e. superclass followed by class (see text)</td><td>A 47-dimensional vector where i<sup>th</sup> position (superclass) and j<sup>th</sup> position (class) are 1, other positions are 0</td></tr><tr><td>PD</td><td>TF has a frequent Pfam domain (yes/no)</td><td>1/0</td></tr><tr><td>DBD</td><td>TF has a DNA-binding domain (DBD) (yes/no)</td><td>1/0</td></tr><tr><td>N_DBD</td><td>Number of DBDs (see text)</td><td>11/10/00</td></tr><tr><td>PPI</td><td>TF has a protein-protein interaction (PPI) (yes/no)</td><td>1/0</td></tr><tr><td>N_PPI</td><td>Number of PPIs (see text)</td><td>11/10/00</td></tr><tr><td>N_PhS</td><td>Number of Phosphorylation sites (see text)</td><td>11/10/00</td></tr><tr><td>PTM</td><td>TF has a post-translational modification (PTM) (yes/no)</td><td>1/0</td></tr><tr><td>Ind_PTM</td><td>TF has a specific PTM (yes/no)</td><td>An ordered 6-dimensional vector where position i corresponding to PTM i is 1/0</td></tr><tr><td>N_ZFD</td><td>Number of the zinc finger domains (see text)</td><td>11/10/00</td></tr></table>
83195f572ca1f684b720505d30cd0220eae525e2011f06747d834e9041dd89ac.png
simple
<table><tr><td>Gender</td><td> </td><td><i>n </i>(%)</td></tr><tr><td> </td><td>Female</td><td>20 (43.5)</td></tr><tr><td> </td><td>Male</td><td>26 (56.5)</td></tr><tr><td>Age</td><td> </td><td>Years (range)</td></tr><tr><td> </td><td>Mean</td><td>32 (18&#8211;37)</td></tr><tr><td>HSCT</td><td> </td><td><i>n </i>(%)</td></tr><tr><td> </td><td>Allogeneic</td><td>31 (67.4)</td></tr><tr><td> </td><td>Autologous</td><td>15 (32.6)</td></tr><tr><td>Underlying disease</td><td> </td><td><i>n </i>(%)</td></tr><tr><td> </td><td>Chronic myelogenous leukemia</td><td>26 (56.5)</td></tr><tr><td> </td><td>Acute myelogenous leukemia</td><td>8 (17.4)</td></tr><tr><td> </td><td>Multiple myeloma</td><td>6 (13.1)</td></tr><tr><td> </td><td>Hodgkin&#8217;s lymphoma</td><td>3 (6.5)</td></tr><tr><td> </td><td>Severe aplastic anemia</td><td>3 (6.5)</td></tr><tr><td>Immunosuppressive conditioning regimen</td><td> </td><td><i>n </i>(%)</td></tr><tr><td> </td><td>Busulfan and melphalan</td><td>30 (65.2)</td></tr><tr><td> </td><td>Busulfan and cyclophosphamide</td><td>4 (8.7)</td></tr><tr><td> </td><td>Total body irradiation and melphalan</td><td>3 (6.5)</td></tr><tr><td> </td><td>Total body irradiation and cyclophosphamide</td><td>3 (6.5)</td></tr><tr><td> </td><td>Other</td><td>6 (13.1)</td></tr></table>
a78c682b0d640055a0452c3a5b0038e102fe153104534f60cf321834c74b6b2a.png
complex
<table><tr><td></td><td colspan="4">Modality</td><td colspan="4">Figurativeness</td></tr><tr><td></td><td colspan="2">Motion metaphor/Auditory metaphor</td><td colspan="2">Motion literal/Auditory literal</td><td colspan="2">Motion literal/Motion metaphor</td><td colspan="2">Auditory literal/Auditory metaphor</td></tr><tr><td></td><td><i>t</i></td><td>Sig.</td><td><i>t</i></td><td>Sig.</td><td><i>t</i></td><td>Sig.</td><td><i>t</i></td><td>Sig.</td></tr><tr><td>Sentence</td></tr><tr><td>Cloze probability</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td></tr><tr><td>Familiarity</td><td></td><td>ns</td><td></td><td>ns</td><td>5.66</td><td>&lt;0.001</td><td>6.91</td><td>&lt;0.001</td></tr><tr><td>Imageability</td><td></td><td>ns</td><td>4.74</td><td>&lt;0.001</td><td>10.13</td><td>&lt;0.001</td><td>5.63</td><td>&lt;0.001</td></tr><tr><td>Figurativeness</td><td></td><td>ns</td><td></td><td>ns</td><td>&#8722;20.95</td><td>&lt;0.001</td><td>&#8722;21.98</td><td>&lt;0.001</td></tr><tr><td>Valence</td><td></td><td>ns</td><td>2.4</td><td>0.02</td><td></td><td>ns</td><td></td><td>ns</td></tr><tr><td>Valence RT</td><td></td><td>ns</td><td>3.1</td><td>0.003</td><td></td><td>ns</td><td>1.99</td><td>0.05</td></tr><tr><td>Pilot accuracy</td><td>1.95</td><td>0.055</td><td></td><td>ns</td><td>2.92</td><td>0.004</td><td>4.59</td><td>&lt;0.001</td></tr><tr><td>Pilot RT</td><td></td><td>ns</td><td></td><td>ns</td><td>&#8722;3.14</td><td>0.002</td><td>&#8722;2.81</td><td>0.006</td></tr><tr><td># characters</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td></tr><tr><td># words</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td></tr><tr><td># content words</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td></tr><tr><td>KF frequency</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td></tr><tr><td>BN frequency</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td></tr><tr><td>Concreteness</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>ns</td></tr><tr><td>Target word</td></tr><tr><td>#characters</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>n/a</td><td></td><td>n/a</td></tr><tr><td>KF frequency</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>n/a</td><td></td><td>n/a</td></tr><tr><td>BN frequency</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>n/a</td><td></td><td>n/a</td></tr><tr><td>Concreteness</td><td></td><td>ns</td><td></td><td>ns</td><td></td><td>n/a</td><td></td><td>n/a</td></tr></table>
016f6c7431897d4879bf4a6f7a2626a2f13827de93bb15de8849b0f4d001d0bf.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">Drainage</td><td colspan="2">No drain</td><td></td></tr><tr><td>Median (25<sup>th</sup> &#8211; 75<sup>th</sup> percentile)</td><td>Mean (&#177; SD)</td><td>Median (25<sup>th</sup> &#8211; 75<sup>th</sup> percentile)</td><td>Mean (&#177; SD)</td><td><i>p</i>-value</td></tr><tr><td>Volume drained (ml)</td><td>500.00 (233.50 &#8211; 864.00)</td><td>581.80 (442.60)</td><td>0.00 (0.00 &#8211; 0.00)</td><td>21.50 (107.90)</td><td>&lt;0.01</td></tr><tr><td>Volume aspirated (ml)</td><td>0.00 (0.00 &#8211; 270.00)</td><td>176.60 (298.20)</td><td>522.50 (130.00 &#8211; 1148.80)</td><td>858.40 (1434.50)</td><td>&lt;0.01</td></tr><tr><td>Number of aspirations</td><td>0.50 (0.00 &#8211; 4.00)</td><td>2.10 (3.10)</td><td>5.00 (3.00 &#8211; 7.00)</td><td>5.90 (6.20)</td><td>&lt;0.01</td></tr><tr><td>Total drained (ml)</td><td>720.00 (395.00 &#8211; 1145.00)</td><td>779.30 (451.90)</td><td>540.00 (215.00 &#8211; 1152.50)</td><td>890.60 (1434.30)</td><td>0.19</td></tr></table>
4dd31d0c7958e24d96878af0efdad9a927e426925a5d849545bac78f01489a79.png
simple
<table><tr><td></td><td>Cluster I</td><td>Cluster II</td><td>Cluster III</td></tr><tr><td>Cluster I</td><td>0</td><td>1.76</td><td>1.72</td></tr><tr><td>Cluster II</td><td>0.14230</td><td>0</td><td>2.80</td></tr><tr><td>Cluster III</td><td>0.14540</td><td>0.08917</td><td>0</td></tr></table>
18a394ba3e33e9be12c452dfec12e8797313101beba6f070f6378723ff562eb2.png
simple
<table><tr><td>Sample sources</td><td>TYLCV positive No./tomato sample No.</td><td>TYLCV positive No./whiltefly No.</td></tr><tr><td>Henan Province</td><td>6,6,6/9<sup>a</sup></td><td>7,7 /22 <sup>b</sup></td></tr><tr><td>Shandong Province</td><td>30,30,30/56</td><td>11,11/20</td></tr><tr><td>Zhejiang Province</td><td>195,195,197 /422</td><td>21,21/68</td></tr><tr><td>Total</td><td>231, 231,233 /487</td><td>39,39/110</td></tr></table>
0e304302c32b80043975c0db421131b20ec83ab0d5d1b83207b350efbdd5375b.png
complex
<table><tr><td>GBB-24 scale and sub-scales</td><td colspan="4">m / M<sub>e</sub>(95%CI)</td><td><i>P</i>-values<sup>a</sup></td></tr><tr><td> </td><td colspan="2">Financial problems</td><td colspan="2">The problems disappeared</td><td> </td></tr><tr><td> </td><td>Yes</td><td>No</td><td>Yes</td><td>No</td><td> </td></tr><tr><td> </td><td>(n=98)</td><td>(n=106)</td><td>(n=83)</td><td>(n=121)</td><td> </td></tr><tr><td rowspan="2">Exhaustion</td><td>8.16 / 8</td><td>6.98 / 7</td><td>6.96 / 7</td><td>7.95 / 7</td><td><sup>1</sup> P=0.108</td></tr><tr><td>(7.18&#8211;9.15)</td><td>(6.14&#8211;7.82)</td><td>(6.04&#8211;7.89)</td><td>(7.06&#8211;8.84)</td><td><sup>2</sup> P=0.225</td></tr><tr><td rowspan="2">Gastrointestinal</td><td>4.19 / 4</td><td>2.72 / 2</td><td>2.55 / 2</td><td>4.03 / 4</td><td><sup>1</sup> P=0.001</td></tr><tr><td>(3.46&#8211;4.93)</td><td>(2.07&#8211;3.37)</td><td>(1.86&#8211;3.25)</td><td>(3.36&#8211;4.69)</td><td><sup>2</sup> P=0.003</td></tr><tr><td rowspan="2">Cardiovascular</td><td>6.61 / 7</td><td>4.77 / 4</td><td>5.10 / 5</td><td>6.04 / 5</td><td><sup>1</sup> P=0.002</td></tr><tr><td>(5.72&#8211;7.51)</td><td>(3.96&#8211;5.59)</td><td>(4.22&#8211;5.98)</td><td>(5.20&#8211;6.88)</td><td><sup>2</sup> P=0.219</td></tr><tr><td rowspan="2">Musculoskeletal</td><td>8.84 / 8.5</td><td>7.59 / 7</td><td>6.80 / 7</td><td>9.14 / 9</td><td><sup>1</sup> P=0.082</td></tr><tr><td>(7.83&#8211;9.85)</td><td>(6.65&#8211;8.52)</td><td>(5.96&#8211;7.63)</td><td>(8.16&#8211;10.12)</td><td><sup>2</sup> P=0.002</td></tr><tr><td>Total GBB-24</td><td>27.81 / 26.5</td><td>22.06 / 20.5</td><td>21.41 / 20</td><td>27.16 / 26</td><td><sup>1</sup> P=0.005</td></tr><tr><td> </td><td>(24.81&#8211;30.81)</td><td>(19.50&#8211;24.61)</td><td>(18.81&#8211;24.00)</td><td>(24.38&#8211;29.94)</td><td><sup>2</sup> P=0.013</td></tr></table>
3a4d4c3b879eea9da59b979547d758ba749a7267f6f45ca0b74042b79967551a.png
complex
<table><tr><td> No. of teeth</td><td colspan="3"> Oral impacts</td><td rowspan="2"> Sn</td><td rowspan="2">Sp</td><td rowspan="2"> PPV</td><td rowspan="2">NPV</td></tr><tr><td>Cutoff</td><td>With</td><td>Without</td><td>Total</td></tr><tr><td>&#8804;24</td><td> 73</td><td> 93</td><td> 166</td><td rowspan="3">0.69</td><td rowspan="3">0.70</td><td rowspan="3"> 0.87</td><td rowspan="3">0.44</td></tr><tr><td>&#8805;25</td><td> 31</td><td> 208</td><td> 239</td></tr><tr><td>Total</td><td> 104</td><td> 301</td><td>405</td></tr></table>
15ed58ccd5e78234143919e8aba14208c931f3843019ad14abe867b1d652a521.png
complex
<table><tr><td>Outcome</td><td>Aligner</td><td>Bracket</td><td><i>P</i>*</td></tr><tr><td></td><td>Mean (SD)</td><td>Mean (SD)</td><td></td></tr><tr><td colspan="4">s-PlI T0 (transformed)</td></tr><tr><td> T0</td><td>5.34 (0.87)</td><td>5.55 (1.08)</td><td>0.56</td></tr><tr><td> T1</td><td>3.97 (1.29)</td><td>5.72 (1.24)</td><td>0.001</td></tr><tr><td> T2</td><td>4.80 (1.48)</td><td>6.15 (1.79)</td><td>0.03</td></tr><tr><td colspan="4">s-GI T0 (transformed)</td></tr><tr><td> T0</td><td>4.35 (0.82)</td><td>5.77 (1.56)</td><td>0.004</td></tr><tr><td> T1</td><td>4.23 (1.29)</td><td>5.71 (1.80)</td><td>0.01</td></tr><tr><td> T2</td><td>5.03 (1.66)</td><td>5.81 (1.69)</td><td>0.21</td></tr></table>
4e2cf266eb2f8a1cf8dc7ed6d492253ffedba10c77b4939530932aeea3fa4486.png
complex
<table><tr><td rowspan="2">Treatment</td><td colspan="2">Superfused bath</td><td colspan="2">Static bath</td><td rowspan="2">Significance (Student&#8217;s t test)</td></tr><tr><td>n</td><td>Released ATP*</td><td>n</td><td>Released ATP*</td></tr><tr><td>Control (Ringer&#8217;s)</td><td>89 puncta, 3 slices</td><td>65 &#177; 1%</td><td>80 puncta, 3 slices</td><td>66 &#177; 2%</td><td><i>p</i> = 0.61</td></tr><tr><td>PPADS</td><td>75 puncta, 2 slices</td><td>62 &#177; 3%</td><td>82 puncta, 2 slices</td><td>64 &#177; 1%</td><td><i>p</i> = 0.41</td></tr><tr><td>&#945;&#946;MeATP</td><td>144 puncta, 4 slices</td><td>73 &#177; 1%</td><td>29 puncta, 1 slice</td><td>70 &#177; 1%</td><td><i>p</i> = 0.09</td></tr></table>
fbb819dd07294a9d3a10835b7192172f70a9e2fc30c64a53044979b5e66f30af.png
simple
<table><tr><td>Media Volume (mL)</td><td>Biomass (mg)</td><td>RGR <sup>1</sup>(mg&#183;mg<sup>&#8722;1</sup>&#183;d<sup>&#8722;1</sup>)</td><td>Dry Weight per mL(mg&#183;mL<sup>&#8722;1</sup>)</td><td>CA Content <sup>2</sup>(&#956;g&#183;gDW<sup>&#8722;1</sup>)</td><td>CA Production <sup>3</sup>(&#956;g&#183;mL<sup>&#8722;1</sup>)</td></tr><tr><td>15</td><td>23.60 &#177; 0.60 <sup>c</sup></td><td>0.378 &#177; 0.002 <sup>c</sup></td><td>1.580 &#177; 0.05 <sup>a</sup></td><td>898.2 &#177; 101 <sup>a</sup></td><td>1.421 &#177; 0.228 <sup>a</sup></td></tr><tr><td>30</td><td>38.00 &#177; 1.14 <sup>b</sup></td><td>0.395 &#177; 0.002 <sup>b</sup></td><td>1.260 &#177; 0.04 <sup>b</sup></td><td>576.8 &#177; 96 <sup>b</sup></td><td>0.735 &#177; 0.174 <sup>b</sup></td></tr><tr><td>60</td><td>61.60 &#177; 1.81 <sup>a</sup></td><td>0.412 &#177; 0.002 <sup>a</sup></td><td>1.040 &#177; 0.02 <sup>c</sup></td><td>335.3 &#177; 64 <sup>c</sup></td><td>0.348 &#177; 0.065 <sup>c</sup></td></tr></table>
b85f19655186c820d7bd14a5df8bbc7c904c457d97a123e4d3639e8e7df13192.png
complex
<table><tr><td>Cluster size</td><td>Hemisphere</td><td>Brain region</td><td>BA</td><td>MNI coordinates</td><td>Peak <i>T</i>-value</td></tr><tr><td colspan="6">POSITIVE RSFCs: PRE &gt; POST</td></tr><tr><td>117</td><td>Right</td><td>Insula/inferior frontal gyrus</td><td>13/45/44</td><td>63, 18, 3</td><td>6.60</td></tr><tr><td>74</td><td>Right</td><td>Middle frontal gyrus/superior frontal gyrus</td><td>6</td><td>33, &#8722;3, 66</td><td>5.14</td></tr><tr><td>64</td><td>Left</td><td>Insula</td><td>13</td><td>&#8722;39, 6, 3</td><td>5.74</td></tr><tr><td colspan="6">NEGATIVE RSFCs: POST &gt; PRE</td></tr><tr><td>119</td><td>Bilateral</td><td>Medial frontal gyrus/superior frontal gyrus</td><td>8</td><td>12, 51, 48</td><td>5.38</td></tr></table>
be85111812350d67fcd61b228ebc3839ad5da1cc1a9d1be24b9f83f5f8f4168d.png
complex
<table><tr><td>Aim</td><td colspan="10">Average-measure reliability <i>G(q,</i>k<i>)</i></td></tr><tr><td>Domain</td><td>Searching for research</td><td>Research obtained</td><td>Relevance appraisal</td><td>Quality appraisal</td><td>Generating new research</td><td>Interacting with researchers</td><td>Conceptual research use</td><td>Instrumental research use</td><td>Tactical research use</td><td>Imposed research use</td></tr><tr><td>(A) Reliability between the two independent coders; <i>q</i> = 0, <i>k</i> = 2</td><td>0.85</td><td>0.88</td><td>0.74</td><td>0.88</td><td>0.93</td><td>0.84</td><td>0.76</td><td>0.77</td><td>0.85</td><td>0.87</td></tr><tr><td>(B) Reliability between the nine experts; <i>q =</i> 0.23, <i>k</i> = 3</td><td>0.77</td><td>0.83</td><td>0.46</td><td>0.74</td><td>0.66</td><td>0.65</td><td>0.58</td><td>0.49</td><td>0.71</td><td>0.89</td></tr></table>
087840edc65c17ca5573d5bc2c7ee0d267ed2192799111e4bfe85db2e8239434.png
simple
<table><tr><td></td><td>Corrected item-total correlation</td><td>Cronbach&#8217;s &#945; if an item deleted</td></tr><tr><td>Item 1</td><td>0.734</td><td>0.876</td></tr><tr><td>Item 2</td><td>0.667</td><td>0.881</td></tr><tr><td>Item 3</td><td>0.563</td><td>0.892</td></tr><tr><td>Item 4</td><td>0.727</td><td>0.876</td></tr><tr><td>Item 5</td><td>0.713</td><td>0.878</td></tr><tr><td>Item 6</td><td>0.716</td><td>0.878</td></tr><tr><td>Item 7</td><td>0.607</td><td>0.886</td></tr><tr><td>Item 8</td><td>0.607</td><td>0.887</td></tr><tr><td>Item 9</td><td>0.641</td><td>0.885</td></tr></table>
7b7c2933a0752cdebf5f564ff2b85dd602c9d262d43e6fc481a574fe4823b355.png
simple
<table><tr><td>Items</td><td>Days to flowering</td><td>Days to maturity</td><td>Plant height</td><td>Branch per plant</td><td>Pods per plant</td><td>Seeds per pod</td><td>100-seed wt (gm)</td><td>Yield perplant</td></tr><tr><td> Days to flowering</td><td>&#8722;0.646</td><td>1.102</td><td>&#8722;0.170</td><td>&#8722;0.141</td><td>0.253</td><td>0.405</td><td>&#8722;0.157</td><td>0.646&#8727;&#8727;</td></tr><tr><td>Days to maturity</td><td>&#8722;0.601</td><td>1.184</td><td>&#8722;0.161</td><td>&#8722;0.111</td><td>0.188</td><td>0.173</td><td>&#8722;0.005</td><td>0.667&#8727;&#8727;</td></tr><tr><td>Plant height (cm)</td><td>&#8722;0.425</td><td>0.736</td><td>&#8722;0.258</td><td>&#8722;0.221</td><td>0.543</td><td>1.050</td><td>&#8722;0.836</td><td>0.589&#8727;&#8727;</td></tr><tr><td>Branches per plant (number) </td><td>&#8722;0.318</td><td>0.459</td><td>&#8722;0.201</td><td>&#8722;0.285</td><td>0.528</td><td>1.150</td><td>&#8722;0.949</td><td>0.387&#8727;</td></tr><tr><td>Pods per plant (number)</td><td>&#8722;0.248</td><td>0.338</td><td>&#8722;0.213</td><td>&#8722;0.228</td><td>0.659</td><td>1.250</td><td>&#8722;1.040</td><td>0.518&#8727;&#8727;</td></tr><tr><td>Seeds per pod (number)</td><td>&#8722;0.180</td><td>0.141</td><td>&#8722;0.187</td><td>&#8722;0.227</td><td>0.569</td><td>1.450</td><td>&#8722;1.168</td><td>0.398&#8727;</td></tr><tr><td>100-seed weight (g)</td><td>0.076</td><td>&#8722;0.0086</td><td>0.161</td><td>0.201</td><td>&#8722;0.510</td><td>&#8722;1.258</td><td>1.350</td><td>0.012</td></tr></table>
aca8f9da0ba8904acc43b441e51f5954788b11ccad0aec7b9ab93072ff972cea.png
complex
<table><tr><td colspan="2"> </td><td> </td><td>Male</td><td>Female</td></tr><tr><td colspan="2"> </td><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>Total</td><td> </td><td>3450 (100)</td><td>1413 (42.0)</td><td>2037 (58.0)</td></tr><tr><td rowspan="5">Age (n=3450)</td><td>15-24</td><td>1100 (28)</td><td>506 (27.9)</td><td>594 (28.0)</td></tr><tr><td>25-34</td><td>721 (24.3)</td><td>280 (25.8)</td><td>441 (23.1)</td></tr><tr><td>35-44</td><td>630 (23.0)</td><td>234 (22.2)</td><td>396 (23.6)</td></tr><tr><td>45-54</td><td>507 (19.2)</td><td>196 (18.7)</td><td>311 (19.7)</td></tr><tr><td>55-64</td><td>492 (5.5)</td><td>197 (5.4)</td><td>295 (5.6)</td></tr><tr><td rowspan="2">Location (n=3450)</td><td>Urban</td><td>1737 (50.3)</td><td>702 (49.6)</td><td>1035 (50.2)</td></tr><tr><td>Rural</td><td>1713 (49.7)</td><td>711 (50.4)</td><td>1002 (49.8)</td></tr><tr><td>Education (n= 3450)</td><td>Primary or less</td><td>219 (6.4)</td><td>107 (7.5)</td><td>112 (5.4)</td></tr><tr><td> </td><td>Secondary School</td><td>2088 (60.5)</td><td>919 (65.0)</td><td>1169 (57.5)</td></tr><tr><td> </td><td>Tertiary Schooling</td><td>1143 (33.1)</td><td>387 (27.4)</td><td>756 (37.1)</td></tr><tr><td rowspan="4">Employment (n=3425)</td><td>Student</td><td>717 (20.8)</td><td>330 (23.7)</td><td>387 (18.8)</td></tr><tr><td>Employed</td><td>1503 (43.6)</td><td>696 (49.9)</td><td>807 (39.5)</td></tr><tr><td>Unemployed</td><td>508 (14.7)</td><td>204 (14.6)</td><td>304 (14.8)</td></tr><tr><td>Retired/Home</td><td>697 (20.2)</td><td>167 (11.8)</td><td>530 (25.9)</td></tr></table>
256805d16c45c913c062081fb0efee0254f132190f255a1453d9bfa4cb414d38.png
simple
<table><tr><td>Question &#8211; Recommender&#8217;s method</td><td>Automation</td><td>Fast enough</td><td>Accuracy</td></tr><tr><td>Which ontologies offer the maximum coverage for my data? &#8211; (CR &#8211; score)</td><td>Yes</td><td>Yes</td><td>Yes</td></tr><tr><td>Which ontologies are reference ontologies for my data? &#8211; (CR+M &#8211; score)</td><td>Yes</td><td>No</td><td>Yes</td></tr><tr><td>Which small ontologies are specialized for my data? &#8211; (CR &#8211; normalized score)</td><td>Yes</td><td>Yes</td><td>Not enough</td></tr></table>
dff2d3557ac91999c78b16279c11718f41f332875c3647c495e038a83fc1854c.png
simple
<table><tr><td>Complication</td><td>Number of patients (<i>n</i>)</td><td>Treatment</td></tr><tr><td>Reflux +/&#8722; heartburn</td><td>21</td><td>Medical +/&#8722; endoscopy +/&#8722; pH 24 h esophageal pH monitoring </td></tr><tr><td>Vomiting</td><td>5</td><td>Diet modifications</td></tr><tr><td>Hemorrhage </td><td>7</td><td>4 surgical, 3 transfusion</td></tr><tr><td>Fistula </td><td>4</td><td>2 surgical, 1 prosthesis 1 surgical + endoscopic</td></tr><tr><td>Fistula + PE</td><td>1</td><td>Surgical</td></tr><tr><td>Abscess </td><td>3</td><td>ATB</td></tr><tr><td>Tachycardia</td><td>1</td><td>CT scan within normal findings</td></tr><tr><td>Dysphagia to meat</td><td>1</td><td>Diet modification</td></tr><tr><td>Dehydration</td><td>1</td><td>Rehospitalisation</td></tr><tr><td>LL sensory disorder</td><td>1</td><td>&#8212;</td></tr><tr><td>Cholelithiasis</td><td>1</td><td>Cholecystectomy</td></tr><tr><td>Failure to lose weight</td><td>2</td><td>&#8212;</td></tr><tr><td>Hypotension &#177; malaise &#177; hypoglycemia</td><td>2</td><td>Rest + NS IV infusion</td></tr><tr><td>Swelling of left internal jugular vein</td><td>1</td><td>&#8212;</td></tr><tr><td>Total</td><td>51</td><td> </td></tr></table>
2b3454d83977be4ab5e018f54dab50dab22b0d803fbff18766cf892bafc56f24.png
simple
<table><tr><td>Maternal</td><td>Neonatal</td><td>Process/intervention</td></tr><tr><td>Gestational weight gain</td><td>Body composition, anthropometry</td><td>Visit attendance</td></tr><tr><td>Preeclampsia*</td><td>Preterm delivery</td><td>Adherence to probiotic/placebo regimen</td></tr><tr><td>Induction of labor</td><td>Shoulder dystocia</td><td> </td></tr><tr><td>Cesarean delivery</td><td>Hypoglycemia</td><td> </td></tr><tr><td> Elective</td><td>Treatment with supplementary fluids/feeds</td><td> </td></tr><tr><td> Emergency</td><td> </td><td> </td></tr><tr><td>Change in prevalence of <i>L. rhamnosus</i> and <i>B. lactis</i> in gut microbiome</td><td>Nerve palsy</td><td> </td></tr><tr><td>Change in lipids and inflammatory profile</td><td>Admission to neonatal intensive care unit</td><td> </td></tr><tr><td>Change in dietary indices and physical activity levels between baseline and 28 weeks gestation</td><td>Jaundice requiring phototherapy</td><td> </td></tr><tr><td> </td><td>Bone fracture</td><td> </td></tr><tr><td> </td><td>Death: stillbirth or neonatal death</td><td> </td></tr></table>
d48e87923585a4a59500ce962ac71c4de8173650e266ed8db7ef1a9c63f73f2d.png
simple
<table><tr><td>Sample</td><td>Total Polyphenol Contents (&#956;g Gallic Acid/mL)</td></tr><tr><td><i>LJ</i></td><td>2.084 &#177; 0.01 <sup>(1)</sup></td></tr><tr><td><i>HF</i></td><td>3.215 &#177; 0.08</td></tr></table>
51de042de96383f957120023cea101ade7a922eea5e4774d187f6e92209c1714.png
simple
<table><tr><td></td><td>CAPEA</td><td>RABBIT</td><td>NDB</td><td>Reference (DEAS)</td></tr><tr><td><i>N</i></td><td>1033</td><td>12,230</td><td>3424</td><td>6202</td></tr><tr><td>Age (years), mean (SD)</td><td>56.6 (14.2)</td><td>56.2 (9.7)</td><td>61.5 (13.7)</td><td>61.5 (12.1)</td></tr><tr><td>Sex (female), n (%)</td><td>660 (63.9)</td><td>9328 (76.3)</td><td>2611 (76.3)</td><td>3072 (49.5)</td></tr><tr><td>Disease duration (weeks or years), mean (SD)</td><td>12.6 w (7.2)</td><td>9.9 y (9.1)</td><td>13.5 y (10.6)</td><td>NA</td></tr><tr><td>CRP (mg/l), mean (SD)</td><td>19.7 (30.3)</td><td>18.2 (26.6)</td><td>11.0 (5.2)</td><td>NA</td></tr><tr><td>DAS28, mean (SD)</td><td>5.1 (1.3)</td><td>5.2 (1.3)</td><td>3.1 (1.2)</td><td>NA</td></tr><tr><td>BMI (kg/m<sup>2</sup>), mean (SD)</td><td>27.0 (5.0)</td><td>26.7 (5.3)</td><td>26.5 (4.9)</td><td>26.6 (4.2)</td></tr><tr><td>&lt; 18.5, n (%)</td><td>11 (1.1)</td><td>263 (2.2)</td><td>56 (1.6)</td><td>45 (0.8)</td></tr><tr><td> 18.5 to &lt;25, n (%)</td><td>372 (36.4)</td><td>4810 (39.3)</td><td>1416 (41.4)</td><td>2264 (37.5)</td></tr><tr><td> 25 to &lt;30, n (%)</td><td>396 (38.8)</td><td>4294 (35.1)</td><td>1219 (35.6)</td><td>2624 (43.5)</td></tr><tr><td>&#8805; 30, n (%)</td><td>243 (23.8)</td><td>2863 (23.4)</td><td>733 (21.4)</td><td>1099 (18.2)</td></tr></table>
5ade0008b55c7f6ee483caa1bd9d2dd6cc62f7366fe96406eb064c2917137f76.png
complex
<table><tr><td rowspan="2">Histology parameters</td><td colspan="3">IBA-1</td><td colspan="3">GFAP</td><td colspan="3">MBP</td><td colspan="3">APP</td></tr><tr><td><i>t</i>(8)</td><td><i>p</i></td><td>Adj <i>p</i></td><td><i>t</i>(8)</td><td><i>p</i></td><td>Adj <i>p</i></td><td><i>t</i>(8)</td><td><i>p</i></td><td>Adj <i>p</i></td><td><i>t</i>(8)</td><td><i>p</i></td><td>Adj <i>p</i></td></tr><tr><td>Anterior Commissure</td><td>1.27</td><td>0.24</td><td>0.56</td><td>0.42</td><td>0.68</td><td>0.94</td><td>4.14</td><td><i>&lt;0.01</i></td><td>0.06</td><td>0.84</td><td>0.43</td><td>0.67</td></tr><tr><td>Brachium_Left</td><td>7.7</td><td><i>&lt;0.01</i></td><td><i>&lt;0.01</i></td><td>6.27</td><td><i>&lt;0.01</i></td><td><i>&lt;0.01</i></td><td>3.11</td><td><i>0.01</i></td><td>0.14</td><td>1.78</td><td>0.11</td><td>0.62</td></tr><tr><td>Brachium_Right</td><td>4.34</td><td><i>&lt;0.01</i></td><td><i>0.04</i></td><td>8.4</td><td><i>&lt;0.01</i></td><td><i>&lt;0.01</i></td><td>3.23</td><td><i>0.01</i></td><td>0.13</td><td>2.9</td><td><i>0.02</i></td><td>0.27</td></tr><tr><td>Cingulum Bundle_Left</td><td>1.52</td><td>0.17</td><td>0.55</td><td>2.29</td><td>0.05</td><td>0.45</td><td>2.43</td><td><i>0.04</i></td><td>0.16</td><td>2.8</td><td><i>0.02</i></td><td>0.3</td></tr><tr><td>Cingulum Bundle_Right</td><td>1.21</td><td>0.26</td><td>0.56</td><td>1.2</td><td>0.26</td><td>0.84</td><td>2.29</td><td>0.05</td><td>0.12</td><td>3.19</td><td><i>0.01</i></td><td>0.2</td></tr><tr><td>Corpus Callosum_Anterior</td><td>4.15</td><td><i>&lt;0.01</i></td><td>0.05</td><td>3.46</td><td><i>0.01</i></td><td>0.12</td><td>3.45</td><td><i>0.01</i></td><td>0.15</td><td>1.91</td><td>0.09</td><td>0.59</td></tr><tr><td>sCorpus Callosum_Posterior</td><td>4.78</td><td><i>&lt;0.01</i></td><td><i>0.02</i></td><td>2.54</td><td><i>0.03</i></td><td>0.39</td><td>2.71</td><td><i>0.03</i></td><td>0.12</td><td>1.41</td><td>0.2</td><td>0.67</td></tr><tr><td>Cortex_Left</td><td>3.01</td><td><i>0.02</i></td><td>0.17</td><td>2.33</td><td>0.05</td><td>0.45</td><td>3.45</td><td><i>0.01</i></td><td><i>0.02</i></td><td>1.28</td><td>0.24</td><td>0.67</td></tr><tr><td>Cortex_Right</td><td>2.34</td><td><i>0.05</i></td><td>0.36</td><td>1.85</td><td>0.1</td><td>0.66</td><td>5.04</td><td><i>&lt;0.01</i></td><td>0.14</td><td>2.3</td><td>0.05</td><td>0.44</td></tr><tr><td>External Capsule_Left</td><td>3.77</td><td><i>0.01</i></td><td>0.07</td><td>1.55</td><td>0.16</td><td>0.79</td><td>2.99</td><td><i>0.02</i></td><td>0.15</td><td>1.23</td><td>0.25</td><td>0.67</td></tr><tr><td>External Capsule_Right</td><td>3.27</td><td><i>0.01</i></td><td>0.13</td><td>1.15</td><td>0.28</td><td>0.84</td><td>2.62</td><td><i>0.03</i></td><td>0.78</td><td>1.75</td><td>0.12</td><td>0.62</td></tr><tr><td>Hippocampus_Left</td><td>2.24</td><td>0.06</td><td>0.37</td><td>1.4</td><td>0.2</td><td>0.79</td><td>0.6</td><td>0.57</td><td>0.78</td><td>2.34</td><td><i>0.05</i></td><td>0.44</td></tr><tr><td>Hippocampus_Right</td><td>2.2</td><td>0.06</td><td>0.37</td><td>1.04</td><td>0.33</td><td>0.84</td><td>0.66</td><td>0.53</td><td>0.14</td><td>2.2</td><td>0.06</td><td>0.45</td></tr><tr><td>Internal Capsule_Left</td><td>1.6</td><td>0.15</td><td>0.55</td><td>0.54</td><td>0.6</td><td>0.94</td><td>3.16</td><td><i>0.01</i></td><td>0.12</td><td>2.49</td><td><i>0.04</i></td><td>0.41</td></tr><tr><td>Internal Capsule_Right</td><td>0.67</td><td>0.52</td><td>0.56</td><td>0.31</td><td>0.76</td><td>0.94</td><td>3.51</td><td><i>0.01</i></td><td>0.12</td><td>3.64</td><td><i>0.01</i></td><td>0.11</td></tr><tr><td>Optic Tract_Left</td><td>4.02</td><td><i>&lt;0.01</i></td><td>0.06</td><td>4.42</td><td><i>&lt;0.01</i></td><td><i>0.03</i></td><td>3.38</td><td><i>0.01</i></td><td>0.12</td><td>1.7</td><td>0.13</td><td>0.62</td></tr><tr><td>Optic Tract_Right</td><td>3.52</td><td><i>0.01</i></td><td>0.1</td><td>6.45</td><td><i>&lt;0.01</i></td><td><i>&lt;0.01</i></td><td>3.16</td><td><i>0.01</i></td><td>0.14</td><td>0.97</td><td>0.36</td><td>0.67</td></tr><tr><td>Thalamus_Left</td><td>2.69</td><td><i>0.03</i></td><td>0.24</td><td>2.38</td><td><i>0.04</i></td><td>0.45</td><td>3.87</td><td><i>&lt;0.01</i></td><td>0.08</td><td>2.4</td><td><i>0.04</i></td><td>0.44</td></tr><tr><td>Thalamus_Right</td><td>1.84</td><td>0.1</td><td>0.48</td><td>1.49</td><td>0.17</td><td>0.79</td><td>3.03</td><td><i>0.02</i></td><td>0.14</td><td>3.91</td><td><i>&lt;0.01</i></td><td>0.08</td></tr></table>
3687848e6850f525014c11cf9c80f3ff201f5add26941100c8a148b96b0a01c1.png
complex
<table><tr><td rowspan="2">Variables</td><td rowspan="2">All cases</td><td colspan="2">miRNA-506 expression</td><td rowspan="2"><i>&#967;</i><sup>2</sup></td><td rowspan="2"><i>p</i>*</td></tr><tr><td>High (<i>n</i> = 60)</td><td>Low (<i>n</i> = 60)</td></tr><tr><td>Age (years)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&#8805;60</td><td>88</td><td>42</td><td>46</td><td></td><td></td></tr><tr><td>&lt;60</td><td>32</td><td>18</td><td>14</td><td>0.289</td><td>0.409</td></tr><tr><td>Gendar</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>81</td><td>36</td><td>45</td><td></td><td></td></tr><tr><td>Female</td><td>39</td><td>24</td><td>15</td><td>0.010</td><td>0.079</td></tr><tr><td>Tumor size (cm)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt;5</td><td>35</td><td>23</td><td>12</td><td></td><td></td></tr><tr><td>&#8805;5</td><td>85</td><td>37</td><td>48</td><td>0.001</td><td>0.027</td></tr><tr><td>Depth of invasion<sup>a</sup></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>m/sm/mp</td><td>49</td><td>29</td><td>20</td><td></td><td></td></tr><tr><td>ss/se/si</td><td>71</td><td>31</td><td>40</td><td>0.014</td><td>0.095</td></tr><tr><td>Tumor differentiation</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Well</td><td>21</td><td>12</td><td>9</td><td></td><td></td></tr><tr><td>Moderate</td><td>30</td><td>18</td><td>12</td><td></td><td></td></tr><tr><td>Poor and others</td><td>69</td><td>30</td><td>39</td><td>0.565</td><td>0.246</td></tr><tr><td>Lymph node invasion</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Absent</td><td>37</td><td>25</td><td>12</td><td></td><td></td></tr><tr><td>Present</td><td>83</td><td>35</td><td>48</td><td>0.000</td><td>0.010</td></tr><tr><td>TNM stage</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>I&#8211;II</td><td>41</td><td>26</td><td>15</td><td></td><td></td></tr><tr><td>III&#8211;IV</td><td>79</td><td>34</td><td>45</td><td>0.002</td><td>0.034</td></tr><tr><td>Metastasis</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>45</td><td>16</td><td>29</td><td></td><td></td></tr><tr><td>No</td><td>75</td><td>44</td><td>31</td><td>0.000</td><td>0.014</td></tr></table>
8fd2fa7d2511770a56cb1a1f86e18c817c4edb3130106b8208781ca681685043.png
simple
<table><tr><td>Participant</td><td>Theme</td><td>Quote</td></tr><tr><td>Female, age 22</td><td>Mitigation</td><td>&#8220;Been getting more hypermobile in the last few days, which shows in the results&#8221;</td></tr><tr><td>Male, age 41</td><td>Response</td><td>&#8220;Feedback is good, I push harder&#8221;</td></tr><tr><td></td><td>Mitigation/pain</td><td>&#8220;I changed how I was bracing myself and used a cushion on the scales for the glute exercise so it hurts less&#8221;</td></tr><tr><td>Female, age 21</td><td>Mitigation</td><td>&#8220;Get a cold, feeling weak but the exercises are fine&#8221;</td></tr><tr><td>Male, age 42</td><td>Mitigation</td><td>&#8220;A bit weaker over the last couple of days because of flu&#8221;</td></tr><tr><td>Male, age 29</td><td>Pain</td><td>&#8220;I had an injury while climbing...it&#8217;s painful&#8221;</td></tr></table>
cd4bbc4a5e247cddb4f073a3d3fbd74c19b47b4ab84426f4fbbe6b57959ac84d.png
complex
<table><tr><td rowspan="3">Variables</td><td colspan="2">High-Sensitivity (<i>n</i> = 23)</td><td colspan="2">Others (<i>n</i> = 34)</td><td rowspan="2"></td></tr><tr><td colspan="2">Female, 78.2%</td><td colspan="2">Female, 50.0%</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td><i>p</i></td></tr><tr><td>Age (y)</td><td>56.35</td><td>15.83</td><td>41.94</td><td>16.35</td><td>0.00**</td></tr><tr><td>Pain Duration (m)</td><td>40.61</td><td>76.48</td><td>73.23</td><td>81.90</td><td>0.10</td></tr><tr><td>250 Hz PTT (mA)</td><td>0.99</td><td>0.56</td><td>6.36</td><td>2.66</td><td>0.00**</td></tr><tr><td>5 Hz PTT (mA)</td><td>1.59</td><td>0.54</td><td>6.01</td><td>2.51</td><td>0.00**</td></tr><tr><td>SF-MPQ sensory score</td><td>13.91</td><td>7.98</td><td>16.29</td><td>7.61</td><td>0.27</td></tr><tr><td>SF-MPQ affective score</td><td>6.42</td><td>3.76</td><td>5.71</td><td>3.53</td><td>0.51</td></tr><tr><td>SF-MPQ Visual Analog Scale</td><td>7.12</td><td>2.36</td><td>6.43</td><td>2.60</td><td>0.32</td></tr><tr><td>SF-MPQ Present Pain Intensity</td><td>3.55</td><td>1.26</td><td>3.26</td><td>1.18</td><td>0.40</td></tr></table>
5b5353f042b2c631bfafc09d4ce43fe1ec3140b8f7a9568e5245346667c5a7a9.png
complex
<table><tr><td>Variable</td><td>Dengue Hemorrhagic Fever (n = 280)</td><td>Dengue Shock Syndrome (n = 11)</td></tr><tr><td></td><td colspan="2">P-value OR (95% CI)</td></tr><tr><td>Presence of bleeding</td><td>0.00070.7 (38.4&#8211;129.9)</td><td>0.000608.2 (33.9&#8211;1008.9)</td></tr><tr><td>Alanine aminotranferase level</td><td>0.0011.9 (0.97&#8211;2.99)</td><td>0.0041.04 (1.015&#8211;1.080)</td></tr><tr><td>Aspartate aminotransferase level</td><td>NS</td><td>0.0101.05 (1.012&#8211;1.088)</td></tr><tr><td>Urinary Proteins</td><td>0.0431.1 (0.191&#8211;1.974)</td><td>NS</td></tr><tr><td>Urinary Red blood cells</td><td>0.0271.4 (0.179&#8211;1.900)</td><td>NS</td></tr><tr><td>Platelet count on admsission less than 50,000 &#215; 10<sup>9</sup>/L</td><td>NS</td><td>0.0140.16 (0.13&#8211;0.19)</td></tr></table>
0dd3e0894f28e772d162e8975f1f064a9319c8e38770286135747e2105218ac3.png
simple
<table><tr><td>Study day</td><td>Date</td><td>Physical examination</td><td>Collar</td><td>Blood</td><td>Skin</td><td>Bone marrow</td></tr><tr><td>Preliminary Screening</td><td>March-April 2012</td><td>+</td><td>-</td><td>+</td><td>-</td><td>-</td></tr><tr><td>Inclusion (D0)</td><td>April-May 2012</td><td>+</td><td>Application</td><td>+</td><td>+</td><td>+</td></tr><tr><td>I Follow-up (D90 &#177; 10)</td><td>July-August 2012</td><td>+</td><td>-</td><td>+</td><td>-</td><td>-</td></tr><tr><td>II Follow-up (D180 &#177; 10)</td><td>October-November 2012</td><td>+</td><td>-</td><td>+</td><td>-</td><td>-</td></tr><tr><td>III Follow-up (D210 &#177; 10)</td><td>November-December 2012</td><td>+</td><td>Removal</td><td>+</td><td>+</td><td>-</td></tr><tr><td>IV Follow-up (D300 &#177; 10)</td><td>February-March 2013</td><td>+</td><td>-</td><td>+</td><td>+</td><td>+</td></tr></table>
34519eb34ba9c1bc2ba9195eaae2ffce4d611e59d4a30673f2546ba8ddb9b466.png
complex
<table><tr><td></td><td></td><td colspan="2">Model 3</td><td></td></tr><tr><td>Tree</td><td>CT</td><td>CLADHC</td><td>HT</td><td>SbST</td></tr><tr><td>1</td><td>40.7 <i>(4.7)</i></td><td><underline>54.0</underline><i> (4.5)</i></td><td>42.0 <i>(5.9)</i></td><td>47.5 <i>(4.7)</i></td></tr><tr><td>2</td><td>31.7 <i>(3.4)</i></td><td>32.7 <i>(3.9)</i></td><td>43.0 <i>(5.9)</i></td><td><underline>45.8</underline><i> (5.3)</i></td></tr><tr><td>3</td><td>26.8 <i>(4.2)</i></td><td><underline>47.9</underline><i> (4.4)</i></td><td>40.7 <i>(6.4)</i></td><td>45.2 <i>(3.5)</i></td></tr><tr><td>4</td><td>34.8 <i>(4.8)</i></td><td>39.2 <i>(4.7)</i></td><td>38.9 <i>(7.0)</i></td><td><underline>47.0</underline><i> (4.4)</i></td></tr><tr><td>5</td><td>41.5 <i>(5.6)</i></td><td><underline>49.7</underline><i> (4.7)</i></td><td>44.2 <i>(6.6)</i></td><td>37.2 <i>(4.6)</i></td></tr><tr><td>6</td><td>42.0 <i>(3.6)</i></td><td>34.8 <i>(4.7)</i></td><td><underline>42.4</underline><i> (5.6)</i></td><td>41.3 <i>(5.3)</i></td></tr><tr><td>7</td><td>28.6 <i>(5.2)</i></td><td>32.1 <i>(4.7)</i></td><td><underline>41.6</underline><i> (6.4)</i></td><td>39.9 <i>(4.3)</i></td></tr><tr><td>8</td><td>33.2 <i>(4.3)</i></td><td><underline>47.2</underline><i> (4.0)</i></td><td>42.9 <i>(6.1)</i></td><td>37.7 <i>(4.0)</i></td></tr><tr><td>9</td><td>33.5 <i>(4.4)</i></td><td>39.1 <i>(4.1)</i></td><td>41.2 <i>(7.0)</i></td><td><underline>48.5</underline><i> (5.3)</i></td></tr><tr><td>10</td><td><underline>65.6</underline><i> (6.6)</i></td><td>48.1 <i>(4.1)</i></td><td>42.1 <i>(7.8)</i></td><td>56.9 <i>(4.2)</i></td></tr><tr><td>Average</td><td>37.84 <i>(4.7)</i></td><td>42.48 <i>(4.4)</i></td><td>41.9 <i>(6.5)</i></td><td><underline>44.7</underline><i> (4.6)</i></td></tr><tr><td>Std dev.<sup>a</sup></td><td>11.07 <i>(0.9)</i></td><td>7.84 <i>(0.3)</i></td><td>1.45 <i>(0.7)</i></td><td>5.94 <i>(0.6)</i></td></tr></table>
a718088b1bb7a6d2cd9c973650041a2bcb35560c900f507cd80dcf01e6b80787.png
simple
<table><tr><td>No.</td><td>Age (years)</td><td>Sex</td><td>Employment</td><td>Period of Residence (years)</td><td>Health Status</td><td>Health Effects</td></tr><tr><td>1</td><td>31</td><td>F</td><td>unemployed</td><td>&gt; 15</td><td>A</td><td>not declared</td></tr><tr><td>2</td><td>39</td><td>F</td><td>commerce</td><td>&gt; 5</td><td>D</td><td>gastrointestinal disease, skin hyperpigmentation</td></tr><tr><td>3</td><td>40</td><td>F</td><td>unemployed</td><td>&gt; 5</td><td>R</td><td>gastrointestinal and respiratory diseases</td></tr><tr><td>4</td><td>41</td><td>F</td><td>commerce</td><td>&gt; 15</td><td>R</td><td>skin hyperpigmentation</td></tr><tr><td>5</td><td>41</td><td>F</td><td>services</td><td>&gt; 5</td><td>R</td><td>gastrointestinal disease</td></tr><tr><td>6</td><td>47</td><td>F</td><td>unemployed</td><td>&lt; 5</td><td>R</td><td>gastrointestinal disease</td></tr><tr><td>7</td><td>49</td><td>F</td><td>unemployed</td><td>&gt; 15</td><td>D</td><td>gastrointestinal disease, skin hyperpigmentation</td></tr><tr><td>8</td><td>51</td><td>F</td><td>unemployed</td><td>&gt; 15</td><td>R</td><td>gastrointestinal and vascular diseases</td></tr><tr><td>9</td><td>54</td><td>F</td><td>farming/commerce</td><td>&gt; 15</td><td>R</td><td>gastrointestinal disease</td></tr><tr><td>10</td><td>56</td><td>F</td><td>farming</td><td>&gt; 15</td><td>A</td><td>not declared</td></tr><tr><td>11</td><td>57</td><td>F</td><td>commerce</td><td>&gt; 15</td><td>R</td><td>gastrointestinal disease</td></tr><tr><td>12</td><td>62</td><td>F</td><td>unemployed</td><td>&gt; 5</td><td>R</td><td>nutritionaldisease (obesity)</td></tr><tr><td>13</td><td>64</td><td>F</td><td>unemployed</td><td>&gt; 15</td><td>D</td><td>vascular disease</td></tr><tr><td>14</td><td>73</td><td>F</td><td>farming</td><td>&gt; 15</td><td>D</td><td>skin hyperpigmentation, tumor</td></tr><tr><td>15</td><td>76</td><td>F</td><td>unemployed</td><td>&gt; 15</td><td>A</td><td>not declared</td></tr><tr><td>16</td><td>46</td><td>M</td><td>mining</td><td>&gt; 15</td><td>R</td><td>respiratory and vascular diseases</td></tr><tr><td>17</td><td>52</td><td>M</td><td>commerce</td><td>&gt; 5</td><td>A</td><td>not declared</td></tr><tr><td>18</td><td>52</td><td>M</td><td>commerce</td><td>&gt; 5</td><td>A</td><td>not declared</td></tr><tr><td>19</td><td>58</td><td>M</td><td>farming</td><td>&gt; 15</td><td>D</td><td>gastrointestinal disease, skin hyperpigmentation</td></tr><tr><td>20</td><td>68</td><td>M</td><td>mining</td><td>&gt; 15</td><td>A</td><td>not declared</td></tr></table>
bb32d820fdc82c7d82b5214e99dd3da9d0867105ce8d7e3ed699ac127c177bab.png
complex
<table><tr><td rowspan="2"><i>Newborn service</i></td><td colspan="3"><i>Coverage of service (%)</i></td></tr><tr><td><i>Indonesia</i></td><td><i>Lao PDR</i></td><td><i>Philippines</i></td></tr><tr><td>Skilled birth attendance*</td><td>83</td><td>42</td><td>72</td></tr><tr><td>Hep B (first dose)</td><td>85</td><td>37 (given at birth)</td><td>87</td></tr><tr><td>Hep B (fourth dose)</td><td>41</td><td>56</td><td>67 (third dose)</td></tr><tr><td>BCG vaccination</td><td>89</td><td>78</td><td>92</td></tr><tr><td>Postpartum care for newborn within two days</td><td>48</td><td>47</td><td>not available</td></tr><tr><td>Newborns that have a reported birth weight (based on either a written record or the mother&#8217;s recall)</td><td>89</td><td>43</td><td>73</td></tr><tr><td>Newborns that received breastfeeding within 1 hour of birth</td><td>49</td><td>39</td><td>54</td></tr></table>
b51434d5035027198fa237f2dff2ef78f48b2e7e2e25ae8ea2eb5c668f12a3f0.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">Experimental (<i>n</i> = 12)</td><td colspan="2">Comparison (<i>n</i> = 8)</td><td rowspan="2"><i>p</i>-Value <sup>b</sup></td></tr><tr><td>Baseline</td><td>10 Weeks</td><td>Baseline</td><td>10 Weeks</td></tr><tr><td>Daily MVPA</td><td>30.7 &#177; 13.2</td><td>34.2 &#177; 18.7</td><td>30.2 &#177; 16.2</td><td>37.8 &#177; 20.4</td><td>0.49</td></tr><tr><td>Daily LPA</td><td>91.4 &#177; 28.8</td><td>98.9 &#177; 29.5</td><td>100.4 &#177; 31.6</td><td>108.5 &#177; 47.9</td><td>0.76</td></tr><tr><td>Daily SB</td><td>464.4 &#177; 50.7</td><td>466.8 &#177; 34.7</td><td>449.2 &#177; 54.9</td><td>449.6 &#177; 53.2</td><td>0.82</td></tr><tr><td>Daily EE</td><td>333.1 &#177; 113.3</td><td>359.9 &#177; 147.4</td><td>395.5 &#177; 229.9</td><td>418.0 &#177; 188.9</td><td>0.44</td></tr><tr><td>Daily steps</td><td>4832.4 &#177; 1816.4</td><td>5175.1 &#177; 2308.2</td><td>4411.6 &#177; 1624.7</td><td>4746.0 &#177; 2044.9</td><td>0.76</td></tr></table>
87bb39877647a2a174bf54355f586fdafcccbd447bf40c9b97c24ac982b88574.png
complex
<table><tr><td></td><td colspan="4">Quartile of serum calcium level (mg/dL)</td></tr><tr><td></td><td>Q<sub>1</sub></td><td>Q<sub>2</sub></td><td>Q<sub>3</sub></td><td>Q<sub>4</sub></td></tr><tr><td>HR (95% CI)</td><td>(&lt;9.0)</td><td>(9.0 - 9.4)</td><td>(9.4 - 9.8)</td><td>(&gt;9.8)</td></tr><tr><td colspan="2"><i>Renal replacement therapy</i></td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>2.12 (1.55-2.91)*</td><td>1.26 (0.90-1.76)</td><td>1.15 (0.79-1.68)</td><td>1 (reference)</td></tr><tr><td>Model 1</td><td>1.52 (1.10-2.10)*</td><td>1.32 (0.94-1.86)</td><td>0.97 (0.67-1.42)</td><td>1 (reference)</td></tr><tr><td>Model 2</td><td>1.64 (1.19-2.26)*</td><td>1.32 (0.94-1.86)</td><td>1.05 (0.72-1.54)</td><td>1 (reference)</td></tr><tr><td>Model 3</td><td>2.34 (1.65-3.31)*</td><td>1.58 (1.11-2.25)*</td><td>1.51 (1.01-2.25)*</td><td>1 (reference)</td></tr><tr><td>Model 4</td><td>2.12 (1.49-3.02)*</td><td>1.50 (1.05-2.15)*</td><td>1.42 (0.95-2.12)</td><td>1 (reference)</td></tr><tr><td colspan="2"><i>Rapid renal function progression</i></td><td></td><td></td><td></td></tr><tr><td>Unadjusted</td><td>1.44 (1.11-1.88)*</td><td>1.18 (0.90-1.54)</td><td>0.94 (0.70-1.26)</td><td>1 (reference)</td></tr><tr><td>Model 1</td><td>1.42 (1.06-1.91)*</td><td>1.28 (0.95-1.71)</td><td>0.93 (0.67-1.28)</td><td>1 (reference)</td></tr><tr><td>Model 2</td><td>1.56 (1.15-2.10)*</td><td>1.30 (0.97-1.75)</td><td>0.98 (0.71-1.36)</td><td>1 (reference)</td></tr><tr><td>Model 3</td><td>1.72 (1.25-2.35)*</td><td>1.40 (1.03-1.91)*</td><td>1.15 (0.82-1.61)</td><td>1 (reference)</td></tr><tr><td>Model 4</td><td>1.65 (1.19-2.27)*</td><td>1.35 (0.99-1.84)</td><td>1.11 (0.79-1.56)</td><td>1 (reference)</td></tr></table>
6b5e4fcea5f24f49d7e464cf7f1cb4bca4d964fcaa693a8cb86d8bb181bd036c.png
complex
<table><tr><td></td><td></td><td></td><td colspan="2">Cell Viability</td></tr><tr><td></td><td>Compound</td><td>Dose</td><td>Human Non-small Cell Lung Cancer</td><td>Normal Diploid Fibroblasts</td></tr><tr><td>X.</td><td>Cyc-[AAAGGGPRGPRPGGGAAA]</td><td>200 &#956;M</td><td>+ + +</td><td>+ + +</td></tr><tr><td>XI.</td><td>Cyc-[GGGGGGPRGPRPGGGGGG]</td><td>200 &#956;M</td><td>+ + +</td><td>+ + +</td></tr><tr><td>XII.</td><td>Cyc-GGGGGGPRGPRPGGGGGG]</td><td>200 &#956;M</td><td>+ + +</td><td>+ + +</td></tr><tr><td>XIII.</td><td>Cyc-[AAGPGGPRGPRPGGPGAA]</td><td>200 &#956;M</td><td>+ + +</td><td>+ + +</td></tr><tr><td>XIV.</td><td>Linear FPPRGPRPVKLALKLALK</td><td>200 &#956;M</td><td>+ + +</td><td>+ + +</td></tr><tr><td>XV</td><td>Linear PRGPRPVALKLALKLAL</td><td>200 &#956;M</td><td>+ + +</td><td>+ + +</td></tr></table>
6c7414937e32afd5255c6482bf2d31e2998bc792a0ad4b10f261915175c6ffff.png
simple
<table><tr><td>Reference</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr><tr><td>Huang (moderate)<sup>1</sup>[34]</td><td>Higher sales of healthier food options were observed in the intervention group compared to the control group.</td><td></td></tr></table>
8b7f724dafd0a23d5cf6a4ea6e0f1d350fc474f5b3c7fa976cff4c2b5f3de6f9.png
simple
<table><tr><td>Work productivity assessment</td><td>No. of patients</td><td>Response, n (%) or mean &#177; SD</td></tr><tr><td>Employed at baseline</td><td>575</td><td>Yes: 262 (45.6)</td></tr><tr><td>Employed when CD symptoms began</td><td>313</td><td>Yes: 161 (51.4)</td></tr><tr><td>Stopped working due to CD</td><td>161</td><td>Yes: 59 (36.6)</td></tr><tr><td>Employment status affected by CD</td><td>262</td><td> &#8226; Different job with less responsibility or pay: 14 (5.3)</td></tr><tr><td></td><td></td><td> &#8226; Same job, reduced hours or responsibility: 50 (19.1)</td></tr><tr><td></td><td></td><td> &#8226; No change: 198 (75.6)</td></tr><tr><td>Missed work in past month due to CD</td><td>261</td><td>Yes: 74 (28.4)</td></tr><tr><td>Number of missed work days in past month</td><td>74</td><td>5.7 &#177; 11.6</td></tr><tr><td>Decreased productivity due to CD</td><td>261</td><td>Yes: 150 (57.5)</td></tr><tr><td>Estimated decrease in work productivity (%)</td><td>150</td><td>72.1 &#177; 20.5</td></tr><tr><td>Have received disability benefits due to CD</td><td>262</td><td>Yes: 12 (4.6)</td></tr><tr><td>Duration of disability benefits (months)</td><td>12</td><td>33.2 &#177; 60.8</td></tr></table>
295023cea8710dde8a6eb081e1c46faf95b031d6639c412cfca86824c6fea4ee.png
simple
<table><tr><td>Species</td><td>Riparian area</td><td>Forest</td><td>Orchards</td><td>High fallows</td><td>Market gardens</td><td>Village</td></tr><tr><td><i>An. braziliensis</i></td><td>2</td><td>-</td><td>-</td><td>-</td><td>1</td><td>2</td></tr><tr><td><i>An. darlingi</i></td><td>81</td><td>-</td><td>6</td><td>10</td><td>78</td><td>97</td></tr><tr><td><i>An. ininii</i></td><td>-</td><td>1</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td><i>An. intermedius</i></td><td>4</td><td>-</td><td>-</td><td>1</td><td>5</td><td>-</td></tr><tr><td><i>An. mediopunctatus</i></td><td>1</td><td>3</td><td>1</td><td>3</td><td>1</td><td>-</td></tr><tr><td><i>An. nuneztovari</i></td><td>14</td><td>-</td><td>4</td><td>15</td><td>14</td><td>1</td></tr><tr><td><i>An. oswaldoi</i></td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td><i>An. peryassui</i></td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td><i>An. strodei</i></td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td></tr><tr><td><i>An. triannulatus</i></td><td>25</td><td>30</td><td>16</td><td>404</td><td>4</td><td>-</td></tr><tr><td>Total</td><td>129</td><td>35</td><td>27</td><td>434</td><td>104</td><td>100</td></tr><tr><td>Species number</td><td>8</td><td>4</td><td>4</td><td>6</td><td>7</td><td>3</td></tr></table>
bf04c3e3cfd5a72e1e3407f417ba709270d8562d70b8cd7e748aafa847177d30.png
simple
<table><tr><td><i>Group</i></td><td><i>n</i></td><td><i>Age (years)</i></td><td><i>Height (cm)</i></td><td><i>Body mass (kg)</i></td></tr><tr><td>AerG</td><td>12</td><td>25 &#177; 5.6</td><td>176.8 &#177; 3.8</td><td>74.7 &#177; 8.2</td></tr><tr><td>ResG</td><td>13</td><td>25 &#177; 3.5</td><td>175.5 &#177; 5.6</td><td>69.1 &#177; 8.5</td></tr><tr><td>ConG</td><td>13</td><td>26 &#177; 3.1</td><td>178.7 &#177; 7.0</td><td>85.0 &#177; 12.8</td></tr><tr><td>NonG</td><td>12</td><td>25 &#177; 2.4</td><td>179.3 &#177; 11.9</td><td>80.3 &#177; 12.8</td></tr></table>
4ccdb038c855c44823522cbc6c51df09d42c2027418e2323267d5203e4105574.png
simple
<table><tr><td>Feature</td><td>Bee</td><td>Fly</td><td>Mosquito</td><td>Moth</td><td>Chafer</td><td>Fruit Fly</td><td>Average Accuracy</td></tr><tr><td>Shape feature</td><td>91.42</td><td>97.67</td><td>98.43</td><td>75.92</td><td>60</td><td>97.05</td><td>86.75</td></tr><tr><td>Texture feature</td><td>78.57</td><td>88.37</td><td>96.87</td><td>79.62</td><td>76</td><td>77.94</td><td>82.90</td></tr><tr><td>Color feature</td><td>41.42</td><td>72.09</td><td>78.12</td><td>85.18</td><td>68</td><td>86.76</td><td>71.93</td></tr><tr><td>HOG feature</td><td>97.46</td><td>91.83</td><td>91.66</td><td>81.66</td><td>84.84</td><td>97.36</td><td>90.80</td></tr><tr><td>Global feature</td><td>97.46</td><td>91.83</td><td>94.44</td><td>98.68</td><td>90</td><td>98.68</td><td>95.18</td></tr><tr><td>Global and local feature</td><td>97.46</td><td>93.87</td><td>97.22</td><td>88.33</td><td>93.93</td><td>98.68</td><td>94.92</td></tr></table>
20d3f846f0e7fba7368f39275c8ec751fb0ad1b6f28144d1610e8073cf7eef86.png
complex
<table><tr><td rowspan="2">Specimen</td><td colspan="2">Culture</td><td colspan="2">Our Taqman PCR Assay</td></tr><tr><td>Positive</td><td>Negative</td><td>Positive</td><td>Negative</td></tr><tr><td>Lung (<i>n</i> = 40)</td><td>17</td><td>23</td><td>39</td><td>1</td></tr><tr><td>Milk(<i>n</i> = 18)</td><td>4</td><td>14</td><td>4</td><td>14</td></tr><tr><td>Swabs(<i>n</i> = 10)</td><td>4</td><td>6</td><td>6</td><td>4</td></tr><tr><td>Joint Fluid (<i>n</i> = 3)</td><td>0</td><td>3</td><td>1</td><td>2</td></tr><tr><td>Total (<i>n</i> = 71)</td><td>25</td><td>46</td><td>50</td><td>21</td></tr></table>
a162839e11fd70366c30cbd231fbe3c2b529e0bf155296969f11b99f51ff55da.png
simple
<table><tr><td>Hose Code</td><td>Shift</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,CCC,*&amp;C,H)H*&amp;,H,HHH,HHH,HHH,CCC/,HHH,HHH,HHH/</td><td>6.89</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,CC,H=C,HHC/,HHC,*C*C,%N,CC,HHC/</td><td>7.88</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,CC,H=C,HHC/,HHC,*C*C,%N,HC,HHC/</td><td>7.88</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,CCC,HHC/,HHC,*C*C,HHH,HHH,HHH,HHC/</td><td>7.19</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=C,=OC/,=OC,*C*N,HC,,HHH/</td><td>7.18</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=C,HHC/,HHC,*C*C,CC,HHC/</td><td>7.14</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=C,HHC/,HHC,*C*C,HC,HCC/</td><td>7.14</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=C,HHC/,HHC,*C*C,HC,HHC/</td><td>7.13</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=C,HHC/,HHC,*N*N,HC,HHC/</td><td>7.13</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=C,HHC/,HHC,=OO,HC,HHC/</td><td>6.99</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=C,HHH/,HHH,*C*C,HC/</td><td>7.10</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=O,HHC/,HHC,*C*C,,HCC/</td><td>7.20</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=O,HHC/,HHC,*C*C,,HHC/</td><td>7.16</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,H=O,HHC/,HHC,=OC,,HHC/</td><td>7.35</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;C,C)H*&amp;,C,HC,HHH,HHC/,HHC,*C*C,HCC/</td><td>7.19</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&amp;Y,C)H*&amp;,C,HC,,HHC/,HHC,*C*C,HHC/</td><td>6.89</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,H*&amp;,C)H*&amp;,C,CC,HHC/,HHC,*C*C,%N,HHC/</td><td>7.10</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,H*&amp;,C)H*&amp;,C,CC,HHH/,HHH,*C*C,%N/</td><td>7.20</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,H*&amp;,C)H*&amp;,C,HC,HHC/,HHC,*C*C,HHC/</td><td>7.13</td></tr></table>
8db6b64e46341b09b696c55014bcdf6a795d07a898c70e06b7594fdf67d42063.png
simple
<table><tr><td>Factor</td><td>B</td><td>SE</td><td>Wald</td><td>df</td><td>p value</td><td>Odds ratio</td><td>95% CI</td></tr><tr><td>Disturbance to studies: yes</td><td>0.740</td><td>0.366</td><td>4.083</td><td>1</td><td><i>0.043</i></td><td><i>2.1</i></td><td><i>1.1&#8211;4.3</i></td></tr><tr><td>Facilities of the classroom: satisfactory</td><td>&#8722; 2.151</td><td>0.327</td><td>43.156</td><td>1</td><td><i>&lt; 0.001</i></td><td><i>0.1</i></td><td><i>0.1&#8211;0.2</i></td></tr><tr><td>Library facilities: satisfactory</td><td>&#8722; 0.691</td><td>0.332</td><td>4.338</td><td>1</td><td><i>0.037</i></td><td><i>0.5</i></td><td><i>0.3&#8211;0.9</i></td></tr><tr><td>School health services: satisfactory</td><td>&#8722; 0.578</td><td>0.328</td><td>3.080</td><td>1</td><td>0.079</td><td>0.6</td><td>0.3&#8211;1.1</td></tr><tr><td>Scope of subject content: satisfactory</td><td>&#8722; 1.464</td><td>0. 357</td><td>16.818</td><td>1</td><td><i>&lt; 0.001</i></td><td><i>0.2</i></td><td><i>0.1&#8211;0.5</i></td></tr><tr><td>Relevance of subject area: satisfactory</td><td>&#8722; 1.900</td><td>0.421</td><td>20.333</td><td>1</td><td><i>&lt; 0.001</i></td><td><i>0.2</i></td><td><i>0.1&#8211;0.3</i></td></tr><tr><td>Difficulty in understanding: easily understood</td><td>&#8722; 1.380</td><td>0.340</td><td>16.444</td><td>1</td><td><i>&lt; 0.001</i></td><td><i>0.3</i></td><td><i>0.1&#8211;0.5</i></td></tr><tr><td>Duration of study: less than 2 h per day</td><td>0.574</td><td>0.325</td><td>3.127</td><td>1</td><td>0.077</td><td>1.8</td><td>0.9&#8211;3.4</td></tr><tr><td>Support from parents: satisfactory</td><td>&#8722; 1.800</td><td>0.488</td><td>13.612</td><td>1</td><td><i>&lt; 0.001</i></td><td><i>0.2</i></td><td><i>0.1&#8211;0.4</i></td></tr><tr><td>Support from teachers: satisfactory</td><td>&#8722; 1.084</td><td>0.449</td><td>5.832</td><td>1</td><td><i>0.016</i></td><td><i>0.3</i></td><td><i>0.1&#8211;0.8</i></td></tr><tr><td>Preference of subject stream: own preference</td><td>&#8722; 1.995</td><td>0.486</td><td>16.825</td><td>1</td><td><i>&lt; 0.001</i></td><td><i>0.1</i></td><td><i>0.1&#8211;0.4</i></td></tr><tr><td>Personal expectations: encouraging</td><td>&#8722; 1.251</td><td>0.576</td><td>4.716</td><td>1</td><td><i>0.030</i></td><td><i>0.3</i></td><td><i>0.1&#8211;0.9</i></td></tr><tr><td>Expectations of parents: encouraging</td><td>&#8722; 1.002</td><td>0.346</td><td>8.375</td><td>1</td><td><i>0.004</i></td><td><i>0.4</i></td><td><i>0.2&#8211;0.7</i></td></tr><tr><td>Subjected to bullying at school: yes</td><td>0.981</td><td>0.302</td><td>10.557</td><td>1</td><td><i>0.001</i></td><td><i>2.7</i></td><td><i>1.5&#8211;4.8</i></td></tr></table>
91cd47c33a50b6c853e25f8ca82254093f5acd9a70c62431c5b2f5618b95be2c.png
simple
<table><tr><td></td><td><i>n </i>(%)</td><td>Median survival (months)</td><td>95% CI<sup>1</sup></td></tr><tr><td>Died during follow-up</td><td>38 (74.5)</td><td></td><td></td></tr><tr><td>Overall survival (months)</td><td></td><td>10.2</td><td>7.5&#8211;13.0</td></tr><tr><td>Gender</td><td>51 (100)</td><td></td><td><i>P</i> = .64</td></tr><tr><td> M</td><td>35 (68.6)</td><td>10.6</td><td>3.4&#8211;17.8</td></tr><tr><td> F</td><td>16 (31.4)</td><td>10.2</td><td>0.0&#8211;22.0</td></tr><tr><td>Age</td><td>51 (100)</td><td></td><td><i>P</i> = .18</td></tr><tr><td> &lt;50</td><td>10 (20)</td><td>5.3</td><td>0.8&#8211;9.8</td></tr><tr><td> &gt;50</td><td>41 (80)</td><td>8.2</td><td>1.8&#8211;19.4</td></tr><tr><td>FUDR given with <sup>90</sup>Y</td><td></td><td></td><td><i>P</i> = .72</td></tr><tr><td> Yes</td><td>17 (33.3)</td><td>17.0</td><td>6.7&#8211;27.3</td></tr><tr><td> No</td><td>34 (66.7)</td><td>8.2</td><td>4.2&#8211;12.3</td></tr><tr><td>Extrahepatic disease present</td><td>48 (100)</td><td></td><td><i>P</i> = .07</td></tr><tr><td> Yes</td><td>28 (58.3)</td><td>6.7</td><td>2.7&#8211;10.6</td></tr><tr><td> No</td><td>20 (41.7)</td><td>17.0</td><td>6.4&#8211;27.6</td></tr><tr><td>CEA response<sup>2</sup></td><td>41 (100)</td><td></td><td><i>P</i> = .36</td></tr><tr><td> Yes</td><td>17 (41.5)</td><td>19.1</td><td>6.3&#8211;31.9</td></tr><tr><td> No</td><td>24 (42.9)</td><td>9.3</td><td>6.0&#8211;12.7</td></tr><tr><td>Radiographic Response<sup>3</sup></td><td>31 (100)</td><td></td><td><i>P</i> = .21</td></tr><tr><td> Progressive Disease</td><td>7 (22.6)</td><td>13.6</td><td>7.4&#8211;19.8</td></tr><tr><td> Stable Disease</td><td>20 (64.5)</td><td>9.3</td><td>6.9&#8211;11.8</td></tr><tr><td> Partial Response</td><td>4 (12.9)</td><td>21.5</td><td>13.7&#8211;29.1</td></tr></table>
654914b0d426c9fd4ec415d2562f78c971961646d135794d432e1a7f4cc425c6.png
simple
<table><tr><td>Method</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Cobb</td><td>&#9642; Simple procedure</td><td>&#9642; No means to quantify rotation from gradation scheme</td></tr><tr><td></td><td>&#9642; Little patient exposure to radiation (one anteroposterior radiograph)</td><td>&#9642; Distortion of spinous process tip in scoliotic vertebrae may decrease accuracy</td></tr><tr><td></td><td></td><td>&#9642; Limited visibility of spinous process on radiographs of vertebrae with large rotation</td></tr><tr><td>Nash-Moe</td><td>&#9642; Position of pedicles are less affected by intravertebral rotation; more reliable landmark for measuring rotation</td><td>&#9642; Provides over-estimation of rotation (can be adjusted by 10&#176; as suggested by Drerup)</td></tr><tr><td></td><td></td><td>&#9642; Pedicles are poorly visible on vertebrae rotated severely or on spines with surgical instrumentation</td></tr><tr><td>Perdriolle</td><td>&#9642; Affordable</td><td>&#9642; Difficulty in making precise markings on radiographs &#8211; a 2 mm error corresponds to 5&#176; rotation</td></tr><tr><td></td><td>&#9642; Non-invasive</td><td></td></tr><tr><td></td><td>&#9642; Simple procedure</td><td></td></tr><tr><td></td><td>&#9642; Little patient exposure to radiation (one anteroposterior radiograph)</td><td>&#9642; Reduced accuracy when measuring large degrees of rotation</td></tr><tr><td></td><td>&#9642; General findings report accurate measurements to within &#177; 5&#176;</td><td></td></tr><tr><td>Stokes</td><td>&#9642; Accounts for three-dimensionality of vertebra; similar accuracy to stereoradiograph</td><td>&#9642; Greater random error in comparison to methods involving marking of vertebral edges</td></tr><tr><td></td><td>&#9642; Little exposure to radiation</td><td></td></tr><tr><td></td><td>&#9642; Simple measuring procedure</td><td></td></tr><tr><td>Aaro-Dahlborn</td><td>&#9642; Better measurement accuracy even when measuring vertebrae tilted in the coronal and saggital planes</td><td>&#9642; More difficult to use for inexperienced observers due to less obvious landmark definitions</td></tr><tr><td>Ho</td><td>&#9642; Clearly defined reference points; simple procedure</td><td>&#9642; Less correlation to actual rotation value when measuring distorted and</td></tr><tr><td></td><td>&#9642; Better interobserver reliability in comparison to Aaro-Dahlborn method when assessing normal vertebrae</td><td>tilted vertebrae; less applicable in realistic conditions</td></tr></table>
e17e8fc8f0bae96a95d3dbeac278a0963edcd1e43189d776cbadc4f6260ac381.png
simple
<table><tr><td>Type</td><td> Male</td><td> Female</td><td> Total</td></tr><tr><td>CO</td><td> 26 (61.9%)</td><td> 16 (38.1%)</td><td> 42</td></tr><tr><td>PP</td><td> 16 (80%)</td><td> 4 (20%)</td><td> 20</td></tr><tr><td>Pl</td><td> 10 (55.6%)</td><td> 8 (44.4%)</td><td> 18</td></tr><tr><td>F/D</td><td> 4 (100%)</td><td> &#8212;</td><td> 4</td></tr><tr><td>Mo</td><td> 2 (33.3%)</td><td> 4 (66.7%)</td><td> 6</td></tr><tr><td>Ge</td><td> 8 (80%)</td><td> 2 (20%)</td><td> 10</td></tr><tr><td>Total</td><td> 66 </td><td> 34</td><td> 100</td></tr></table>
5747516d270f3048cc1c1fea11f20b96fd90467f9b08ef07572b64e003d0158d.png
simple
<table><tr><td></td><td>Up-regulated</td><td>Down-regulated</td><td>Total</td></tr><tr><td>Rep1</td><td>90</td><td>86</td><td>176</td></tr><tr><td>Rep2</td><td>77</td><td>89</td><td>166</td></tr><tr><td>Rep1&amp; Rep2</td><td>15</td><td>15</td><td>30</td></tr></table>
d3e199c5e3e62d1baf5dc8e5680956a2a036dfe7a2b4d3a358bc7d1e24f1e085.png
complex
<table><tr><td rowspan="2">Group</td><td rowspan="2">Habituation</td><td>Day 1</td><td>Day 2</td><td>Day 2 - 4</td><td>Day 5 - 8</td><td>Day 9</td><td>Day 9 - 13</td><td>Day 14</td><td>Day 14 - 19</td><td>Day 20</td></tr><tr><td>Stress 1 &#215; 15 min</td><td>Decap</td><td>Stress 2 &#215; 10 min</td><td>Stress 3 &#215; 10 min</td><td>Decap</td><td>Stress 3 &#215; 10 min</td><td>Decap</td><td>No stress</td><td>Decap</td></tr><tr><td>Stress 1</td><td>V</td><td>V</td><td>V</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Control 1</td><td>V</td><td>V</td><td>V</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Stress 2</td><td>V</td><td>V</td><td></td><td>V</td><td>V</td><td>V</td><td></td><td></td><td></td><td></td></tr><tr><td>Control 2</td><td>V</td><td>V</td><td></td><td>V</td><td>V</td><td>V</td><td></td><td></td><td></td><td></td></tr><tr><td>Stress 3</td><td>V</td><td>V</td><td></td><td>V</td><td>V</td><td></td><td>V</td><td>V</td><td></td><td></td></tr><tr><td>Control 3</td><td>V</td><td>V</td><td></td><td>V</td><td>V</td><td></td><td>V</td><td>V</td><td></td><td></td></tr><tr><td>Stress 4</td><td>V</td><td>V</td><td></td><td>V</td><td>V</td><td></td><td>V</td><td></td><td>V</td><td>V</td></tr><tr><td>Control 4</td><td>V</td><td>V</td><td></td><td>V</td><td>V</td><td></td><td>V</td><td></td><td>V</td><td>V</td></tr></table>
700b87a6daf9760c409a3306707d5c653c5b82a51da2c514c4110723f946916e.png
simple
<table><tr><td>Milestone</td><td>Date</td></tr><tr><td>Review of lower risk drinking guidelines announced</td><td>March 2012</td></tr><tr><td>Expert group assessment of the need to update the guidelines</td><td>2013&#8211;2014</td></tr><tr><td>Guidelines development group considered the evidence and produced advice on revisions to the guidelines</td><td>2014&#8211;2015</td></tr><tr><td>Publication of proposed revisions</td><td>January 2016</td></tr><tr><td>Public consultation on the clarity of the guidelines concluded</td><td>April 2016</td></tr><tr><td>Final guidelines released</td><td>August 2016</td></tr></table>
1535ebea7cf0b5943082a82733ae504d8122950ec9b97b64b0fe986e444969f2.png
simple
<table><tr><td>Drug Name</td><td>Drug Function</td><td>Reference</td></tr><tr><td>Trimetazidine</td><td>Cytoprotective, anti-ischemic</td><td>[78,79]</td></tr><tr><td>Isoflurane</td><td>Cytoprotective</td><td>[80]</td></tr><tr><td>Erythropoietin</td><td>Anti-apoptotic</td><td>[77]</td></tr><tr><td>Deferoxamine:</td><td>HIF-1&#945; stabilizer</td><td>[81,82]</td></tr><tr><td>Dimethyloxalylglycine</td><td>HIF-1&#945; stabilizer</td><td>[83]</td></tr><tr><td>Antimycin</td><td>Mitochondrial inhibitor</td><td>[75]</td></tr><tr><td>Oxytocin</td><td>Anti-oxidant</td><td>[84]</td></tr><tr><td>Celastrol</td><td>Anti-oxidant</td><td>[85]</td></tr><tr><td>Melatonin</td><td>Anti-oxidant</td><td>[86,87]</td></tr><tr><td>Nicorandil</td><td>K<sup>+</sup> channel activator</td><td>[88]</td></tr><tr><td>Diazoxide</td><td>K<sup>+</sup> channel activator</td><td>[76]</td></tr><tr><td>Lipopolysaccharide</td><td>TRL4 agonist</td><td>[89]</td></tr><tr><td>Pioglitazone</td><td>PPAR-&#947; agonists</td><td>[90]</td></tr><tr><td>NaHS</td><td>H<sub>2</sub>S donor</td><td>[91]</td></tr></table>
1a25c6896836c430c0c07bba6513fc360e8f36aa7a32c56ab467dd62dcf88503.png
complex
<table><tr><td>Study*</td><td>30-day major complications</td><td>30-day minor complications</td><td>Pulmonary embolism</td><td>Deep venous thrombosis</td><td>Readmissions in the first 30 postoperative days</td></tr><tr><td>Abdalla [15]</td><td>1</td><td>5</td><td>0</td><td>0</td><td>NR<sup>1</sup></td></tr><tr><td>Buchs [16]</td><td colspan="2">24 (not classified)</td><td>7</td><td>2</td><td>2</td></tr><tr><td>Hagen [7]</td><td colspan="2">23 (not classified)</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Tieu [17]</td><td>45</td><td>102</td><td>2</td><td>3</td><td>67</td></tr><tr><td>Vilallonga [18]</td><td>1 case</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Ayloo [19]</td><td colspan="2">NR</td><td>NR</td><td>NR</td><td>0</td></tr><tr><td>Diamantis [20]</td><td colspan="2">0 (not classified)</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Edelson [21]</td><td colspan="2">NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Park [22]</td><td colspan="2">10 (not classified)</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Scozzari [8]</td><td>4</td><td>14</td><td>1</td><td>NR</td><td>NR</td></tr><tr><td>Curet [23]</td><td colspan="2">3 (not classified)</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Deng [24]</td><td>4</td><td>7</td><td>NR</td><td>NR</td><td>3</td></tr><tr><td>Hubens [25]</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Sudan [26]</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Parini [27]</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Mohr [28]</td><td>6</td><td>7</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Yu [29]</td><td>NR</td><td>NR</td><td>1</td><td>NR</td><td>NR</td></tr><tr><td>Ali [30]</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Artuso [31]</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Galvani [32]</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Sanchez [33]</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Muhlmann [34]</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr></table>
c9690a1275fcca362d19cd94c8d4761684d7f45e7ac1ffd917e1cda50aa4defe.png
simple
<table><tr><td>Step</td><td>Predictor variable</td><td>&#916;<i>F</i></td><td><i>R</i><sup>2</sup></td><td>&#916;<i>R</i><sup>2</sup></td><td>&#223;</td><td><i>p</i></td></tr><tr><td></td><td>OVERALL</td></tr><tr><td>1</td><td>Age</td><td>19.065</td><td>0.238</td><td>&#8211;</td><td>&#8722;0.413</td><td>0.001</td></tr><tr><td></td><td>Sex</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>0.220</td><td>0.007</td></tr><tr><td>2</td><td>BDI score</td><td>9.249</td><td>0.292</td><td>0.054</td><td>&#8722;0.236</td><td>0.003</td></tr><tr><td></td><td>FEMALES</td></tr><tr><td>1</td><td>Age</td><td>16.228</td><td>0.167</td><td>&#8211;</td><td>&#8722;0.409</td><td>0.001</td></tr><tr><td>2</td><td>BDI score</td><td>0.522</td><td>0.172</td><td>0.005</td><td>&#8722;0.077</td><td>0.472</td></tr><tr><td></td><td>MALES</td></tr><tr><td>1</td><td>Age</td><td>10.376</td><td>0.206</td><td>&#8211;</td><td>&#8722;0.454</td><td>0.003</td></tr><tr><td>2</td><td>BDI score</td><td>25.059</td><td>0.517</td><td>0.311</td><td>&#8722;0.560</td><td>0.001</td></tr></table>
158a8e76239fa396f07e48d9c4ca5e5da6fc687eba197df1013a06c4a46f32ca.png
simple
<table><tr><td>Variable</td><td>N(%) = 604(100%)</td></tr><tr><td>Gender (male)</td><td>417(69%)</td></tr><tr><td>Age (yrs)</td><td>60.2(&#177; 12.5)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>26.5(24.3-29.4)</td></tr><tr><td>Race (Caucasian)</td><td>560(92.7)</td></tr><tr><td>Cause of CKD</td><td></td></tr><tr><td> Diabetic nephropathy</td><td>65(10.8%)</td></tr><tr><td> Renovascular</td><td>188(31.1%)</td></tr><tr><td> Glomerular disease</td><td>109(18%)</td></tr><tr><td> Interstitial disease</td><td>57(9.4%)</td></tr><tr><td> Congenital (incl PKD)</td><td>62(10.3%)</td></tr><tr><td> Unknown</td><td>123(20.4%)</td></tr><tr><td>History of CVD</td><td>178(29.5%)</td></tr><tr><td>Diabetes Mellitus</td><td>144(23.8%)</td></tr><tr><td>Hypertension</td><td>433(71.7%)</td></tr><tr><td>Smoking</td><td>145(24%)</td></tr><tr><td>Systolic BP (mmHg)</td><td>136(&#177; 21)</td></tr><tr><td>Diastolic BP (mmHg)</td><td>78(&#177; 11)</td></tr><tr><td>Creatinine (&#956;mol/l)</td><td>184(&#177; 71)</td></tr><tr><td>eGFR (MDRD, ml/min/1.73 m<sup>2</sup>)</td><td>36.8(&#177; 13.9)</td></tr><tr><td>Total cholesterol (mmol/l)</td><td>4.8(&#177; 1.0)</td></tr><tr><td>Proteinuria (g/24 hours)</td><td>0.3(0.1-0.9)</td></tr><tr><td>Phosphate (mmol/l)</td><td>1.12(&#177; 0.26)</td></tr><tr><td>Calcium (mmol/l)</td><td>2.38(&#177; 0.14)</td></tr><tr><td>PTH (pmol/l)</td><td>8.3(5.6-14.4)</td></tr><tr><td>cFGF23 (RU/ml)</td><td>116(67-203)</td></tr><tr><td>Medication</td><td></td></tr><tr><td> Active vitamin D (any)</td><td>135(22.4)</td></tr><tr><td> Phosphate binders (any)</td><td>56(9.3)</td></tr></table>
22888166946b2b65769cc39e736cacb82becafa38d3ce9675a39997e6cae4f44.png
complex
<table><tr><td><i>IFN</i>-<i>&#947;</i>-1616 T/C Genotypes</td><td>OR<sup>&#8225;</sup>(95% CI)</td><td><i>P</i>value</td></tr><tr><td>TT</td><td>5.53 (2.30- 13.27)</td><td>&lt;0.001</td></tr><tr><td>TC</td><td>1.00</td><td></td></tr><tr><td>CC</td><td>0.65 (0.15- 2.80)</td><td>0.56</td></tr><tr><td>Alleles frequency</td><td></td><td></td></tr><tr><td>T</td><td rowspan="2">0.28 (0.10- 0.76)</td><td rowspan="2">0.008</td></tr><tr><td>C</td></tr></table>
acc02e96550368d8e968e4ad25560aacfaef996e72b01d524dca0bc7c6e1b92a.png
simple
<table><tr><td>Time (years)</td><td>Transformation rate</td><td>Standard error</td><td>95% confidence interval</td></tr><tr><td>1</td><td>0.0119</td><td>0.0015</td><td>0.0093-0.0154</td></tr><tr><td>2</td><td>0.0232</td><td>0.0022</td><td>0.0192-0.0279</td></tr><tr><td>3</td><td>0.0290</td><td>0.0025</td><td>0.0244-0.0343</td></tr><tr><td>4</td><td>0.0385</td><td>0.0030</td><td>0.0329-0.0449</td></tr><tr><td>5</td><td>0.0461</td><td>0.0034</td><td>0.0398-0.0534</td></tr><tr><td>6</td><td>0.0543</td><td>0.0039</td><td>0.0471-0.0624</td></tr><tr><td>7</td><td>0.0594</td><td>0.0042</td><td>0.0517-0.0681</td></tr><tr><td>8</td><td>0.0615</td><td>0.0044</td><td>0.0535-0.0706</td></tr><tr><td>9</td><td>0.0669</td><td>0.0050</td><td>0.0578-0.0773</td></tr><tr><td>10</td><td>0.0689</td><td>0.0053</td><td>0.0592-0.0802</td></tr></table>
be92e4811f9c78a9f65f876505e35ba04ec7a665ee457729cf6e08345e2f8807.png
simple
<table><tr><td>Receptor</td><td>Ligand 7</td><td>Ligand 11</td><td>Ligand 15</td></tr><tr><td>CA-II</td><td>6</td><td>0</td><td>5</td></tr><tr><td>Cat B</td><td>8</td><td>1</td><td>3</td></tr><tr><td>DNA-1</td><td>5</td><td>2</td><td>7</td></tr><tr><td>DNA-2</td><td>2</td><td>2</td><td>5</td></tr><tr><td>Gyrase</td><td>3</td><td>1</td><td>6</td></tr><tr><td>HDAC7</td><td>3</td><td>0</td><td>3</td></tr><tr><td>HIS</td><td>4</td><td>1</td><td>4</td></tr><tr><td>Kinase</td><td>5</td><td>0</td><td>4</td></tr><tr><td>rHA</td><td>4</td><td>2</td><td>2</td></tr><tr><td>RNR</td><td>6</td><td>1</td><td>7</td></tr><tr><td>Top II</td><td>9</td><td>4</td><td>7</td></tr><tr><td>TrxR</td><td>6</td><td>4</td><td>3</td></tr><tr><td>TS</td><td>7</td><td>4</td><td>7</td></tr></table>
0649c8d3475dc9d567946a1107ba0d00cb9b3b866d3947094e672277b57cbb2f.png
complex
<table><tr><td></td><td colspan="2">Number of</td><td></td><td colspan="2">Number of</td></tr><tr><td>Condition</td><td>Trials</td><td>Patients</td><td>Drug treaments</td><td>Trial arms</td><td>Contributing patients</td></tr><tr><td>Arthritis</td><td>16</td><td>2990</td><td>Opioid</td><td>24</td><td>2173</td></tr><tr><td></td><td></td><td></td><td>Placebo</td><td>7</td><td>445</td></tr><tr><td></td><td></td><td></td><td>Other comparator</td><td>2</td><td>447</td></tr><tr><td>Musculoskeletal</td><td>10</td><td>1648</td><td>Opioid</td><td>18</td><td>1561</td></tr><tr><td></td><td></td><td></td><td>Placebo</td><td>4</td><td>302</td></tr><tr><td></td><td></td><td></td><td>Other comparator</td><td>0</td><td>0</td></tr><tr><td>Neuropathic</td><td>5</td><td>302</td><td>Opioid</td><td>5</td><td>219</td></tr><tr><td></td><td></td><td></td><td>Placebo</td><td>4</td><td>178</td></tr><tr><td></td><td></td><td></td><td>Other comparator</td><td>1</td><td>46</td></tr><tr><td>Mixed conditions</td><td>3</td><td>606</td><td>Opioid</td><td>6</td><td>606</td></tr><tr><td></td><td></td><td></td><td>Placebo</td><td>1</td><td>49</td></tr><tr><td></td><td></td><td></td><td>Other comparator</td><td>0</td><td>0</td></tr></table>
3198d29452e25533d50bce0be8469c86ba4093fcf9c002782258b0b561b09d39.png
simple
<table><tr><td>Sub-groups</td><td>T1DM patients (<i>N</i> = 216)</td><td>Controls (<i>N</i> = 204)</td><td><i>p</i>-value</td><td>OR<sup>a</sup></td><td>CI<sup>b</sup></td></tr><tr><td>Deficient</td><td>182 (84 %)</td><td>158 (77 %)</td><td>0.046</td><td>1.66</td><td>1.02&#8211;2.701</td></tr><tr><td>Insufficient</td><td>31 (15 %)</td><td>29 (14 %)</td><td>0.93</td><td>0.977</td><td>0.565&#8211;1.689</td></tr><tr><td>Sufficient</td><td>3 (1 %)</td><td>11 (5 %)</td><td>0.027</td><td>0.239</td><td>0.0658&#8211;0.872</td></tr><tr><td>Defficient + Insufficient</td><td>213 (99 %)</td><td>187 (92 %)</td><td>0.027</td><td>4.176</td><td>1.147&#8211;15.202</td></tr></table>
6436a10cb29bc91a618cdf1e8da0399578de9da87de9dfd786b05507afd23911.png
simple
<table><tr><td>Participants</td><td>Gender</td><td>Years of implant</td><td>Etiology</td><td>Implantation site</td></tr><tr><td>F.R.</td><td>M</td><td>9</td><td>Neurofibratosis type 2</td><td>Brainstem</td></tr><tr><td>D.M.</td><td>M</td><td>13</td><td>Trauma with bilateral cochlear fracture</td><td>Brainstem</td></tr><tr><td>M.A.</td><td>F</td><td>16</td><td>Congenital hearing loss</td><td>Cochlea</td></tr><tr><td>P.S.</td><td>M</td><td>15</td><td>Congenital hearing loss</td><td>Cochlea</td></tr><tr><td>M.G.</td><td>M</td><td>12</td><td>Congenital hearing loss</td><td>Cochlea</td></tr><tr><td>G.A.</td><td>F</td><td>16</td><td>Congenital hearing loss</td><td>Cochlea</td></tr></table>
39d37e67af8c377f9618160b041ce098e1d1568fd0b3c9d2b1acd9ccb8755184.png
complex
<table><tr><td> </td><td colspan="5">Boys</td><td colspan="5">Girls</td></tr><tr><td> </td><td colspan="2">&lt;11 years</td><td colspan="2">&#8805;11 years</td><td> </td><td colspan="2">&lt;10 years</td><td colspan="2">&#8805;10 years</td><td> </td></tr><tr><td> </td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td><td>P value</td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td><td>P value</td></tr><tr><td>Y1</td><td>32</td><td>0.53 (0.36)</td><td>22</td><td>0.24 (0.34)</td><td>0.0046</td><td>12</td><td>0.42 (0.51)</td><td>10</td><td>0.29 (0.38)</td><td>0.5159</td></tr><tr><td>Y2</td><td>25</td><td>0.94 (0.65)</td><td>13</td><td>0.47 (0.50)</td><td>0.0284</td><td>6</td><td>0.77 (0.55)</td><td>5</td><td>0.49 (0.67)</td><td>0.4726</td></tr><tr><td>Y3</td><td>16</td><td>0.92 (0.65)</td><td>10</td><td>1.01 (0.65)</td><td>0.7168</td><td>2</td><td>1.24 (0.33)</td><td>3</td><td>1.24 (0.45)</td><td>0.9968</td></tr><tr><td>Y4</td><td>6</td><td>1.15 (0.93)</td><td>8</td><td>0.90 (0.88)</td><td>0.6082</td><td>2</td><td>1.34 (0.78)</td><td>1</td><td>1.52 (&#8212;)</td><td>&#8212;</td></tr></table>
492335f8678281b22ee1e5f3e86b8fd1eff138a3a1f798f62974df3b42989680.png
complex
<table><tr><td>Variables</td><td>b (SE)</td><td>Beta</td><td>p-value</td></tr><tr><td>Intercept</td><td>14.71</td><td colspan="2"></td></tr><tr><td>Pain (VAS)</td><td>0.77 (0.35)</td><td>0.31</td><td>0.03</td></tr><tr><td>Gender (female vs male)</td><td>6.48 (2.00)</td><td>0.39</td><td>0.00</td></tr><tr><td>Age (years)</td><td>-0.27 (0.11)</td><td>-0.32</td><td>0.02</td></tr><tr><td>Stiffness (WOMAC)</td><td>1.05 (0.43)</td><td>0.30</td><td>0.02</td></tr><tr><td>Maximum walking speed (m/s)</td><td>9.59 (3.54)</td><td>0.41</td><td>0.01</td></tr><tr><td></td><td colspan="3">R<sup>2 </sup>= 0.47 p &lt; 0.001</td></tr></table>
ea7dea7c717d3cfc962baa9db64c1b0b969e18fd43c7ef75e8640c3c2cece9f9.png
simple
<table><tr><td>Gene symbol</td><td>Description</td><td>Log<sub>2</sub>FC</td><td><i>P</i><sub>adjusted</sub></td></tr><tr><td><i>FLAI-K-feline</i></td><td><i>Feline class I antigen-alpha chain-like class I antigen</i></td><td><i>1.7066</i></td><td>4.95E&#8722;06*</td></tr><tr><td><i>LOC101084108</i></td><td>HLA class II histocompatibility antigen, DM alpha chain</td><td>0.24295</td><td>0.50201</td></tr><tr><td><i>LOC101082906</i></td><td>HLA class II histocompatibility antigen DO beta chain</td><td>0.06259</td><td>0.8714</td></tr><tr><td><i>LOC101090265</i></td><td>HLA class II histocompatibility antigen, DM beta chain</td><td>&#8722;0.52204</td><td>0.24494</td></tr><tr><td><i>LOC101098301</i></td><td>DLA class II histocompatibility antigen, DR-1 beta chain</td><td>&#8722;0.61283</td><td>0.2607</td></tr><tr><td><i>LOC101088734</i></td><td>HLA class II histocompatibility antigen DR alpha chain-like</td><td>&#8722;0.63486</td><td>0.24216</td></tr><tr><td><i>HMHA1</i></td><td>Minor human histocompatibility protein HA-1</td><td>&#8722;0.67421</td><td>0.0512</td></tr></table>
1722f77feea4598a54484e30800addc7c374b96e1dd9b576fb46f9f9ca1bfa8a.png
simple
<table><tr><td><i>Immunophenotypic marker</i></td><td><i>MLL rearrangement (n = 11)</i></td><td><i>Hyperdiploidy (n = 34)</i></td><td><i>t (12;21) (n = 21)</i></td><td><i>t (1;19) (n = 5)</i></td><td><i>Rare (n = 8)</i></td><td><i>Normal karyotype (n = 28)</i></td><td>Total (n = 107)*</td><td>p-Value</td></tr><tr><td>CD10</td><td>27%(3/11&#167;)</td><td>53%(18/34)</td><td>67%(14/21)</td><td>80%(4/5)</td><td>63%(5/8)</td><td>50%(14/28)</td><td>58%(62/107)</td><td><i>ns</i></td></tr><tr><td>CD33</td><td>9.1%(1/11&#167;)</td><td>31%(9/29)</td><td>45%(9/20)</td><td>20%(1/5)</td><td>25%(2/8)</td><td>42%(10/24)</td><td>33%(32/97)</td><td><i>ns</i></td></tr><tr><td>CD13</td><td>18%(2/11)</td><td>19%(6/31)</td><td>15%(3/20)</td><td>20%(1/5)</td><td>38%(3/8)</td><td>7%(2/27)</td><td>17%(17/102)</td><td><i>ns</i></td></tr><tr><td>CD123</td><td>9.1%(1/11)</td><td>6%(2/32)</td><td>17%(3/18)</td><td>20%(1/5)</td><td>25%(2/8)</td><td>7%(2/28)</td><td>8.8%(10/114)</td><td><i>ns</i></td></tr><tr><td>CD15/CD65</td><td>18%(2/11)</td><td>9%(3/32)</td><td>16%(3/19)</td><td>20%(1/5)</td><td>13%(1/8)</td><td>4%(1/26)</td><td>11%(11/101)</td><td><i>ns</i></td></tr><tr><td>&#8805; 1 altered phenotypic marker</td><td>73%(8/11)</td><td>77%(24/31)</td><td>85%(17/20)</td><td>100%(5/5)</td><td>75%(6/8)</td><td>76%(19/25)</td><td>79%(79/100)</td><td><i>ns</i></td></tr></table>
7baf7b539ab663981c131792096aa84c133b51f74a13385189e89a45a619dbc9.png
complex
<table><tr><td rowspan="2">Clinicopathological features</td><td rowspan="2">N</td><td colspan="2">STK31 methylation</td><td rowspan="2">p</td></tr><tr><td>+</td><td>-</td></tr><tr><td>Age</td><td>148</td><td></td><td></td><td></td></tr><tr><td>&lt;45</td><td></td><td>49</td><td>13</td><td>0.741</td></tr><tr><td>&#8805;45</td><td></td><td>66</td><td>20</td><td></td></tr><tr><td>Histology</td><td>102</td><td></td><td></td><td></td></tr><tr><td>Squamous cell carcinoma</td><td></td><td>67</td><td>13</td><td>1.000</td></tr><tr><td>Adenocarcinoma</td><td></td><td>18</td><td>4</td><td></td></tr><tr><td>Differentiation</td><td>146</td><td></td><td></td><td></td></tr><tr><td>Well + Moderate</td><td></td><td>75</td><td>17</td><td>0.584</td></tr><tr><td>Poor</td><td></td><td>42</td><td>12</td><td></td></tr><tr><td>Lymph node metastasis</td><td>100</td><td></td><td></td><td></td></tr><tr><td>Positive</td><td></td><td>23</td><td>7</td><td>0.708</td></tr><tr><td>Negative</td><td></td><td>56</td><td>14</td><td></td></tr><tr><td>FIGO stage</td><td>119</td><td></td><td></td><td></td></tr><tr><td>IA1 ~ IIA2</td><td></td><td>50</td><td>14</td><td>0.617</td></tr><tr><td>IIB ~ IIIA</td><td></td><td>45</td><td>10</td><td></td></tr><tr><td>Tumor size (cm)</td><td>148</td><td></td><td></td><td></td></tr><tr><td>&lt;1</td><td></td><td>40</td><td>11</td><td>0.877</td></tr><tr><td>&#8805;1</td><td></td><td>75</td><td>22</td><td></td></tr><tr><td>HPV16/18</td><td>134</td><td></td><td></td><td></td></tr><tr><td>No(HPV-negative)</td><td></td><td>18</td><td>0</td><td>0.037</td></tr><tr><td>Yes</td><td></td><td>87</td><td>29</td><td></td></tr><tr><td>HPV genotyping</td><td>123</td><td></td><td></td><td></td></tr><tr><td>HPV16</td><td></td><td>81</td><td>19</td><td>0.711</td></tr><tr><td>HPV18</td><td></td><td>20</td><td>3</td><td></td></tr><tr><td>Squamous cell carcinoma-Ag(SCC-Ag)</td><td>80</td><td></td><td></td><td></td></tr><tr><td>Normal</td><td></td><td>24</td><td>4</td><td>1.000</td></tr><tr><td>High</td><td></td><td>45</td><td>7</td><td></td></tr><tr><td>Neoajuvant Chemotherapy</td><td>55</td><td></td><td></td><td></td></tr><tr><td>No</td><td></td><td>23</td><td>7</td><td>0.029</td></tr><tr><td>Yes</td><td></td><td>25</td><td>0</td><td></td></tr><tr><td>Neoajuvant Chemotherapy resistance</td><td>55</td><td></td><td></td><td></td></tr><tr><td>No</td><td></td><td>44</td><td>9</td><td>0.037</td></tr><tr><td>Yes</td><td></td><td>0</td><td>2</td><td></td></tr></table>
96358570a2041c6494fe5cd72f0256604fe3b139e2a9b1b54902fa5c80e0121f.png
complex
<table><tr><td colspan="2">Recommendation</td><td>Quality of evidence</td><td>Strength of recommendation</td><td>Rationale (Benefits, harms and the preferences of patients and clinicians)</td></tr><tr><td>1</td><td>Victims with potential spinal injury should have spinal stabilisation.</td><td>Very low</td><td>Strong</td><td>Paucity of literature supporting spinal stabilisation. Very little literature documenting serious harm. Spinal cord injury can have devastating consequences. Potential benefits outweigh harms</td></tr><tr><td>2</td><td>A minimal handling strategy should be observed.</td><td>Very low</td><td>Strong</td><td>Paucity of literature supporting spinal stabilisation. Very little literature documenting serious harm. Spinal cord injury can have devastating consequences. Potential benefits outweigh possible harms</td></tr><tr><td>3</td><td>Spinal stabilisation should never delay or preclude life-saving intervention in the critically injured trauma victim.</td><td>Very low</td><td>Good clinical practice</td><td>Literature supporting this recommendation was considered too heterogenous for synthesis. The faculty finds that it is logical that spinal stabilisation in the critically injured patient may cause serious harm</td></tr><tr><td>4</td><td>Victims of isolated penetrating injury should not be immobilised.</td><td>Moderate</td><td>Strong</td><td>One large study of moderate quality directly supports this recommendation. Spinal injury in patients with isolated penetrating injury is rare</td></tr><tr><td>5</td><td>Triaging tools based on clinical findings should be implemented.</td><td>Moderate</td><td>Strong</td><td>Consistent evidence supporting triaging tools based on clinical findings rather than mechanism. No harmful effects documented</td></tr><tr><td>6</td><td>Cervical stabilisation may be achieved using manual in-line stabilisation, head-blocks, a rigid collar or combinations thereof.</td><td>Very low</td><td>Conditional</td><td>Consistent experimental evidence demonstrating how rigid collars can stabilise the cervical spine. However, there is also evidence suggesting harm from rigid collars. No evidence proving superiority of any one method</td></tr><tr><td>7</td><td>Transfer from the ground or between stretchers should be achieved using a scoop stretcher.</td><td>Very low</td><td>Conditional</td><td>General paucity of evidence. Some evidence for significant spinal motion during log-roll. Some evidence documenting improved stability with scoop stretcher transfers. Safety of scoop stretcher systems is good. No harmful effects documented</td></tr><tr><td>8</td><td>Patients with potential spinal injury should be transported strapped supine on a vacuum mattress or on an ambulance stretcher system.</td><td>Very low</td><td>Conditional</td><td>Evidence supporting harm from hard surface stretcher systems. No consistent evidence demonstrating increased stability with any one method. Increased comfort associated with soft surface systems. No evidence exploring spinal stability of common stretcher systems</td></tr><tr><td>9</td><td>Hard surface stretcher systems may be used for transports of shorter duration only.</td><td>Very low</td><td>Conditional</td><td>Evidence supporting harm from hard surface stretcher systems. No consistent evidence demonstrating increased stability with any one method. Increased comfort associated with soft surface systems</td></tr><tr><td>10</td><td>Patients should under some circumstances be invited to self-extricate from vehicles.</td><td>Very low</td><td>Conditional</td><td>Two experimental studies demonstrating improved stability with self-extrication from vehicles. Reasonable and practical alternative as long as used cautiously</td></tr></table>
6606ab586111301841830ae53e171d342e9289b684fbbdfbe0e7c4e08a3012d2.png
simple
<table><tr><td><i>x</i><sub>1</sub></td><td><i>x</i><sub>2</sub></td><td><i>x</i><sub>3</sub></td><td><i>x</i><sub>4</sub></td><td><i>x</i><sub>5</sub></td><td><i>x</i><sub>6</sub></td></tr><tr><td>.688</td><td>.352</td><td>&#8722;.083</td><td>.096</td><td>&#8722;.301</td><td>&#8722;.105</td></tr><tr><td>.733</td><td>.352</td><td>.104</td><td>&#8722;.176</td><td>.087</td><td>&#8722;.411</td></tr><tr><td>.856</td><td>&#8722;.167</td><td>&#8722;.204</td><td>.208</td><td>.006</td><td>&#8722;.123</td></tr><tr><td>.709</td><td>&#8722;.405</td><td>&#8722;.357</td><td>&#8722;.210</td><td>&#8722;.085</td><td>.019</td></tr><tr><td>.479</td><td>&#8722;.478</td><td>&#8722;.376</td><td>&#8722;.468</td><td>&#8722;.025</td><td>.254</td></tr><tr><td>.721</td><td>.101</td><td>&#8722;.470</td><td>.200</td><td>.318</td><td>&#8722;.100</td></tr><tr><td>.562</td><td>.302</td><td>&#8722;.362</td><td>.543</td><td>&#8722;.259</td><td>&#8722;.054</td></tr><tr><td>.530</td><td>.365</td><td>.566</td><td>&#8722;.072</td><td>&#8722;.109</td><td>.410</td></tr><tr><td>.545</td><td>.574</td><td>.130</td><td>&#8722;.027</td><td>.253</td><td>.204</td></tr><tr><td>&#8722;.043</td><td>.528</td><td>.660</td><td>.227</td><td>&#8722;.017</td><td>&#8722;.173</td></tr><tr><td>&#8722;.039</td><td>.145</td><td>.182</td><td>.358</td><td>.799</td><td>.283</td></tr><tr><td>.445</td><td>&#8722;.638</td><td>.352</td><td>.448</td><td>.033</td><td>&#8722;.124</td></tr><tr><td>.464</td><td>&#8722;.662</td><td>.260</td><td>.479</td><td>&#8722;.028</td><td>&#8722;.092</td></tr><tr><td>.877</td><td>&#8722;.369</td><td>&#8722;.011</td><td>.015</td><td>.002</td><td>&#8722;.096</td></tr><tr><td>.919</td><td>&#8722;.239</td><td>&#8722;.094</td><td>.040</td><td>&#8722;.017</td><td>.079</td></tr><tr><td>.767</td><td>.142</td><td>&#8722;.093</td><td>.267</td><td>&#8722;.132</td><td>.050</td></tr><tr><td>.853</td><td>.282</td><td>.085</td><td>&#8722;.019</td><td>.203</td><td>&#8722;.097</td></tr><tr><td>.476</td><td>&#8722;.442</td><td>.662</td><td>&#8722;.246</td><td>&#8722;.124</td><td>&#8722;.070</td></tr><tr><td>.664</td><td>&#8722;.374</td><td>.577</td><td>&#8722;.255</td><td>&#8722;.021</td><td>&#8722;.007</td></tr><tr><td>.802</td><td>.388</td><td>.147</td><td>&#8722;.092</td><td>&#8722;.079</td><td>.054</td></tr><tr><td>.623</td><td>.237</td><td>.052</td><td>&#8722;.517</td><td>&#8722;.025</td><td>.047</td></tr><tr><td>.634</td><td>&#8722;.269</td><td>&#8722;.143</td><td>&#8722;.157</td><td>.559</td><td>.179</td></tr><tr><td>.374</td><td>.072</td><td>&#8722;.051</td><td>.299</td><td>&#8722;.427</td><td>.671</td></tr><tr><td>.672</td><td>.547</td><td>&#8722;.187</td><td>&#8722;.154</td><td>&#8722;.037</td><td>&#8722;.187</td></tr></table>
16c08e0c19f15545da6fecc55af765cf2d0e79b36a4bf669db6d0f5a2daa6e4d.png
simple
<table><tr><td>Target</td><td>Efficiency LNA primers</td><td>Efficiency DNA primers</td><td>Difference</td></tr><tr><td>let-7a</td><td>82%</td><td>89%</td><td>6.9%</td></tr><tr><td>miR-101a</td><td>85%</td><td>90%</td><td>4.9%</td></tr><tr><td>miR-103</td><td>93%</td><td>94%</td><td>1.6%</td></tr><tr><td>miR-122</td><td>95%</td><td>95%</td><td>-0.1%</td></tr><tr><td>miR-125b</td><td>89%</td><td>94%</td><td>4.5%</td></tr><tr><td>miR-139b-5p</td><td>79%</td><td>86%</td><td>6.4%</td></tr><tr><td>miR-150</td><td>84%</td><td>97%</td><td>12.6%</td></tr><tr><td>miR-199b-3p</td><td>80%</td><td>87%</td><td>7.1%</td></tr><tr><td>miR-20a</td><td>88%</td><td>86%</td><td>-2.0%</td></tr><tr><td>miR-200b</td><td>80%</td><td>94%</td><td>13.6%</td></tr><tr><td>miR-200c</td><td>83%</td><td>84%</td><td>0.2%</td></tr><tr><td>miR-21</td><td>91%</td><td>92%</td><td>1.1%</td></tr><tr><td>miR-23a</td><td>79%</td><td>93%</td><td>14.1%</td></tr><tr><td>miR-23b</td><td>81%</td><td>87%</td><td>6.2%</td></tr><tr><td>miR-25</td><td>84%</td><td>91%</td><td>6.7%</td></tr><tr><td>miR-26a</td><td>88%</td><td>96%</td><td>8.3%</td></tr><tr><td>miR-27a</td><td>86%</td><td>85%</td><td>-1.1%</td></tr><tr><td>let-7d</td><td>not specific</td><td>102%</td><td></td></tr><tr><td>Average</td><td>85%</td><td>90%</td><td>5.4%</td></tr></table>
6286007f859fe05e6e07a0b9bed07f872836b86f5df1de6f036eb14ec9df53f2.png
complex
<table><tr><td></td><td colspan="2">P1</td><td colspan="2">N1</td><td colspan="2">P2</td></tr><tr><td></td><td>Control</td><td>Patient</td><td>Control</td><td>Patient</td><td>Control</td><td>Patient</td></tr><tr><td colspan="7">AVERAGE AMPLITUDE</td></tr><tr><td>Standard</td><td>0.281</td><td>0.463</td><td>0.290</td><td>0.031</td><td>0.552</td><td>0.635</td></tr><tr><td>Low deviant</td><td>0.324</td><td>0.337</td><td>&#8722;0.941</td><td>&#8722;0.468</td><td>0.705</td><td>0.812</td></tr><tr><td>High deviant</td><td>&#8722;0.080</td><td>0.219</td><td>&#8722;1.614</td><td>&#8722;0.95</td><td>0.357</td><td>0.299</td></tr><tr><td colspan="7">PEAK LATENCY</td></tr><tr><td>Standard</td><td>77</td><td>84</td><td>135</td><td>135</td><td>187</td><td>197</td></tr><tr><td>Low deviant</td><td>68</td><td>73</td><td>150</td><td>152</td><td>242</td><td>240</td></tr><tr><td>High deviant</td><td>65</td><td>75</td><td>133</td><td>139</td><td>246</td><td>232</td></tr></table>
dc14599f76f6a7c7a8ff2363abc40227cf1b64021a6a3c890500cfd5b1798842.png
simple
<table><tr><td>Nutrient</td><td>Oxygen (kJ/l)</td><td>Carbon dioxide (kJ/l)</td></tr><tr><td>Carbohydrate</td><td>21.1</td><td>21.1</td></tr><tr><td>Protein</td><td>18.7</td><td>23.4</td></tr><tr><td>Fat</td><td>19.6</td><td>27.8</td></tr></table>
146939c099484ec3dd533e85bb97f349b3068504e3e58abca78c036a5f9ae10f.png
simple
<table><tr><td>Activities</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>1</td><td>0.000</td><td>0.039</td><td>0.007</td><td>0.154</td><td>0.357</td><td>0.405</td><td>0.194</td><td>0.090</td></tr><tr><td>2</td><td>0.039</td><td>0.000</td><td>0.032</td><td>0.115</td><td>0.396</td><td>0.444</td><td>0.233</td><td>0.129</td></tr><tr><td>3</td><td>0.007</td><td>0.032</td><td>0.000</td><td>0.147</td><td>0.364</td><td>0.412</td><td>0.200</td><td>0.097</td></tr><tr><td>4</td><td>0.154</td><td>0.115</td><td>0.147</td><td>0.000</td><td>0.511</td><td>0.559</td><td>0.347</td><td>0.244</td></tr><tr><td>5</td><td>0.357</td><td>0.396</td><td>0.364</td><td>0.511</td><td>0.000</td><td>0.048</td><td>0.163</td><td>0.267</td></tr><tr><td>6</td><td>0.405</td><td>0.444</td><td>0.412</td><td>0.559</td><td>0.048</td><td>0.000</td><td>0.212</td><td>0.315</td></tr><tr><td>7</td><td>0.194</td><td>0.233</td><td>0.200</td><td>0.347</td><td>0.163</td><td>0.212</td><td>0.000</td><td>0.103</td></tr><tr><td>8</td><td>0.090</td><td>0.129</td><td>0.097</td><td>0.244</td><td>0.267</td><td>0.315</td><td>0.103</td><td>0.000</td></tr></table>
07ab9cb393a30b215487f71f80bce778b247eecb3f74beb70fc784a368801eeb.png
complex
<table><tr><td rowspan="2">Spiked conc.(&#956;g/ml)</td><td colspan="3">Between-day assay (n=6)</td><td colspan="3">Within-day assay (n=6)</td></tr><tr><td>Mean</td><td>SD</td><td>RSD (%)</td><td>Mean</td><td>SD</td><td>RSD (%)</td></tr><tr><td>5 </td><td>5.9</td><td>0.5</td><td>8.5</td><td>5.4</td><td>0.9</td><td>16.7</td></tr><tr><td>50</td><td>49.8</td><td>4.5</td><td>11</td><td>52.4</td><td>5.6</td><td>10.7</td></tr><tr><td>200</td><td>217.2</td><td>21.7</td><td>10.0</td><td>217.2</td><td>26.6</td><td>12.2</td></tr></table>
f314212f46129079a45835c178a7031ba5f369c63e6acaaf9ee078eb86052309.png
simple
<table><tr><td></td><td>PM (n = 11)</td><td>DM (n = 38)</td><td>Total (n = 49)</td></tr><tr><td>Age at diagnosis (years)&#8224;</td><td>51.1 &#177; 15.8</td><td>43.7 &#177; 13.9</td><td>45.4 &#177; 14.6</td></tr><tr><td>Gender (F:M)</td><td>7:4</td><td>23:15</td><td>30:19</td></tr><tr><td>Disease duration (months)&#8224;</td><td>44.2 &#177; 46.9</td><td>62.9 &#177; 53.0</td><td>59.1 &#177; 51.9</td></tr><tr><td>Clinical manifestation, n (%)</td><td></td><td></td><td></td></tr><tr><td> Fever</td><td>3 (27.3)</td><td>11 (28.9)</td><td>14 (28.6)</td></tr><tr><td> Raynaud's phenomenon</td><td>2 (18.2)</td><td>6 (15.8)</td><td>8 (16.3)</td></tr><tr><td> Arthralgia</td><td>2 (18.2)</td><td>14 (36.8)</td><td>16 (32.7)</td></tr><tr><td> Dysphagia</td><td>0 (0)</td><td>9 (23.7)</td><td>9 (18.4)</td></tr><tr><td> Cardiac involvement</td><td>2 (18.2)</td><td>0 (0)</td><td>2 (4.1)</td></tr><tr><td> ILD</td><td>2 (18.2)</td><td>12 (31.6)</td><td>14 (28.6)</td></tr><tr><td> Malignancy</td><td>3 (27.3)</td><td>9 (23.7)</td><td>12 (24.5)</td></tr><tr><td> Myositis overlap</td><td>1 (9.1)</td><td>2 (5.3)</td><td>3 (6.1)</td></tr></table>
7a102ec52d90d4b74928cebc2c2ea87377207509a87fe0b674b99a0118701ff5.png
complex
<table><tr><td colspan="2">Total particles (by optical particle counter)</td><td colspan="4">Viral particles (by RT-PCR analysis)</td></tr><tr><td rowspan="2">Particle size range (&#956;m)</td><td rowspan="2">Average removal efficiency (%)</td><td rowspan="2">Particle size range (&#956;m)</td><td colspan="3">Average removal efficiency (%)</td></tr><tr><td>IAV</td><td>PRRSV</td><td>PEDV</td></tr><tr><td>0.3&#8211;0.5</td><td>51.6</td><td>0.4&#8211;0.7</td><td>77.1</td><td>98.4</td><td>89.9</td></tr><tr><td>0.5&#8211;1.0</td><td>56.1</td><td>0.7&#8211;1.1</td><td>52</td><td>&#8211;<sup>a</sup></td><td>95.5</td></tr><tr><td>1.0&#8211;3.0</td><td>76.2</td><td>1.1&#8211;2.1</td><td>77.7</td><td>&#8211;</td><td>58.8</td></tr><tr><td>3.0&#8211;5.0</td><td>82.2</td><td>2.1&#8211;3.3</td><td>77.5</td><td>97.8</td><td>89.8</td></tr><tr><td>5.0&#8211;10.0</td><td>79.8</td><td>3.3&#8211;4.7</td><td>98.2</td><td>99.7</td><td>96.4</td></tr><tr><td>&gt;10</td><td>76.2</td><td>4.7&#8211;5.8</td><td>96.5</td><td>98.8</td><td>89.7</td></tr><tr><td></td><td></td><td>5.8&#8211;9.0</td><td>97</td><td>98.2</td><td>85.1</td></tr><tr><td></td><td></td><td>&gt;9.0</td><td>98.2</td><td>99.9</td><td>84.3</td></tr></table>
38ac12af0f4e45278aedfd4f26964f4915d629d8eec21d1596c115fe120f0906.png
complex
<table><tr><td> </td><td>Training</td><td>Tuning</td><td>Testing</td></tr><tr><td colspan="4">French</td></tr><tr><td>Titles</td><td>458,543</td><td>57,317</td><td>57,317</td></tr><tr><td>Abstracts (hr=0.0)</td><td>28,882</td><td>28,882</td><td>28,881</td></tr><tr><td>Abstracts (hr=0.29)</td><td>17,351</td><td>17,365</td><td>28,881</td></tr><tr><td colspan="4">Spanish</td></tr><tr><td>Titles</td><td>198,512</td><td>24,814</td><td>24,814</td></tr><tr><td>Abstracts (hr=0.0)</td><td>7,772</td><td>7,772</td><td>7,772</td></tr><tr><td>Abstracts (hr=0.29)</td><td>5,403</td><td>5,418</td><td>7,772</td></tr></table>
fdbd617074428e0d609bf0a0f7812a56c299b45f1a2e88d9ba260004051f4f90.png
complex
<table><tr><td>Demographic variable</td><td></td><td>Pre (N = 88)</td><td colspan="2">Post (N = 69)</td><td></td></tr><tr><td></td><td></td><td>n (%)</td><td colspan="2">n (%)</td><td>Test statistics</td></tr><tr><td rowspan="2">Gender</td><td>Female</td><td>63(72)</td><td colspan="2">53(77)</td><td>x2 = 0.546, <i>df</i> = 1, p = 0.46</td></tr><tr><td>Male</td><td>25(28)</td><td colspan="2">16(23)</td><td></td></tr><tr><td rowspan="2">Scenario version</td><td>CT ICU scenario</td><td>48(55)</td><td colspan="2">45(65)</td><td>x2 = 1.824, <i>df</i> = 1, p = 0.177</td></tr><tr><td>Gen ICU scenario</td><td>40(45)</td><td colspan="2">24(35)</td><td></td></tr><tr><td rowspan="5">Age</td><td>20 - 29</td><td>21(24)</td><td colspan="2">21(30)</td><td>x2 = 2.566, <i>df</i> = 4, p = 0.63</td></tr><tr><td>30 - 39</td><td>43(49)</td><td colspan="2">29(42)</td><td></td></tr><tr><td>40 - 49</td><td>20(23)</td><td colspan="2">18(26)</td><td></td></tr><tr><td>50 - 59</td><td>3(3)</td><td colspan="2">1(1)</td><td></td></tr><tr><td>60 - 69</td><td>1(1)</td><td colspan="2"></td><td></td></tr><tr><td rowspan="4">Current unit*</td><td></td><td>[n = 76]</td><td colspan="2">[n = 58]</td><td>x2 = 3.469, <i>df</i> = 2, p = 0.176</td></tr><tr><td>Private ICU</td><td>25(33)</td><td colspan="2">17(29)</td><td></td></tr><tr><td>General ICU</td><td>32(42)</td><td colspan="2">18(31)</td><td></td></tr><tr><td>Cardiothoracic ICU</td><td>19(25)</td><td colspan="2">23(40)</td><td></td></tr><tr><td rowspan="5">Current designation</td><td>RN</td><td>56(64)</td><td colspan="2">39(567)</td><td>x2 = 5.331, <i>df</i> = 6, p = 0.502</td></tr><tr><td>CNS</td><td>20(23)</td><td colspan="2">19(27)</td><td></td></tr><tr><td>RMO</td><td>3(3)</td><td colspan="2">1(1)</td><td></td></tr><tr><td>Registrar/Senior Registrar</td><td>5(6))</td><td colspan="2">7(10)</td><td></td></tr><tr><td>Consultant</td><td>4(4)</td><td colspan="2">2(3)</td><td></td></tr><tr><td rowspan="2">Role</td><td>Nurse</td><td>76(86)</td><td colspan="2">58(84)</td><td>x2 = 0.164, <i>df</i> = 1, p = 0.69</td></tr><tr><td>Doctor</td><td>12(14)</td><td colspan="2">11(16)</td><td></td></tr><tr><td rowspan="3">Current employment type</td><td>Full Time</td><td>64(73)</td><td colspan="2">47(69)</td><td>x2 = 1.154, <i>df</i> = 3, p = 0.76</td></tr><tr><td>Part Time</td><td>22(25)</td><td colspan="2">20(29)</td><td></td></tr><tr><td>Casual/Other</td><td>2(2)</td><td colspan="2">1(1)</td><td></td></tr><tr><td rowspan="8">Highest level of education</td><td>Hospital Certificate</td><td>3(4)</td><td colspan="2"></td><td>x2 = 7.35, <i>df</i> = 8, p = 0.499</td></tr><tr><td>Associate Diploma/Diploma</td><td>8(9)</td><td colspan="2">2(3)</td><td></td></tr><tr><td>Bachelors Degree</td><td>39(44)</td><td colspan="2">28(41)</td><td></td></tr><tr><td>Graduate Certificate</td><td>21(24)</td><td colspan="2">20(29)</td><td></td></tr><tr><td>Graduate Diploma</td><td>6(7)</td><td colspan="2">9(13)</td><td></td></tr><tr><td>Masters Degree</td><td>8(9)</td><td colspan="2">8(12)</td><td></td></tr><tr><td>PhD</td><td>1(1)</td><td colspan="2">1(1)</td><td></td></tr><tr><td>Other</td><td>2(2)</td><td colspan="2">1(1)</td><td></td></tr><tr><td>Enrolled in higher degree study<sup>^</sup></td><td>Yes</td><td>25(29)</td><td colspan="2">13(20)</td><td>x2 = 1.642, <i>df</i> = 1, p = 0.20</td></tr><tr><td rowspan="5">Level of higher degree study enrolled in<sup>^</sup></td><td></td><td>[n = 25]</td><td colspan="2">[n = 13]</td><td>x2 = 3.562, <i>df</i> = 4, p = 0.47</td></tr><tr><td>Graduate Certificate/Diploma</td><td>14(56)</td><td colspan="2">6(50)</td><td></td></tr><tr><td>Masters Degree by coursework</td><td>5(20)</td><td colspan="2">4(33)</td><td></td></tr><tr><td>PhD</td><td>2(8)</td><td colspan="2">2(17)</td><td></td></tr><tr><td>Other</td><td>4(16)</td><td colspan="2"></td><td></td></tr><tr><td></td><td>mean(SD)</td><td>range</td><td>mean(SD)</td><td>range</td><td></td></tr><tr><td>Years employed in current unit<sup>^</sup></td><td>5.09(6.09)</td><td>3 weeks to 38 yrs</td><td>4.61(4.57)</td><td>1 month to 18 yrs</td><td>t = 0.561, df = 151.63, p = 0.576</td></tr><tr><td>Years of ICU experience</td><td>7.03(6.55)</td><td>3 weeks to 38 yrs</td><td>6.58(5.70)</td><td>1 month to 21 yrs</td><td>t = 0.457, df = 153.24, p = 0.649</td></tr></table>
360747d8f3f118be1590577c409365fa5692af8e35ab1fed492c31b4b9913c21.png
complex
<table><tr><td></td><td></td><td colspan="2">Wheeze</td><td colspan="2">Asthma</td><td colspan="2">Eczema</td><td colspan="2">Rhinoconjunctivitis</td></tr><tr><td></td><td>N</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Smoking status</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Never</td><td>1182</td><td>105</td><td>8.9%</td><td>58</td><td>4.9%</td><td>146</td><td>12.4%</td><td>302</td><td>25.6%</td></tr><tr><td>Former</td><td>503</td><td>65</td><td>12.9%</td><td>31</td><td>6.2%</td><td>72</td><td>14.3%</td><td>133</td><td>26.4%</td></tr><tr><td>Current</td><td>58</td><td>12</td><td>20.7%</td><td>7</td><td>12.1%</td><td>8</td><td>13.8%</td><td>17</td><td>29.3%</td></tr><tr><td>Pack-years of smoking</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>None</td><td>1182</td><td>105</td><td>8.9%</td><td>58</td><td>4.9%</td><td>146</td><td>12.4%</td><td>302</td><td>25.6%</td></tr><tr><td>0.05-3.9</td><td>262</td><td>27</td><td>10.3%</td><td>11</td><td>4.2%</td><td>36</td><td>13.7%</td><td>68</td><td>26.0%</td></tr><tr><td>&#8805; 4.0</td><td>299</td><td>50</td><td>16.7%</td><td>27</td><td>9.0%</td><td>44</td><td>14.7%</td><td>82</td><td>27.4%</td></tr></table>
b31705660248743a89396b54b1beae7442d19ac7d2aab92d37d2ee77a8e76fa6.png
complex
<table><tr><td rowspan="2">Growth Variable</td><td>Exclusively Breastfed (<i>n</i> = 62)</td><td>Exclusively Formula Fed (<i>n</i> = 12)</td><td>Solid Foods with Partial Breastfeeding (<i>n</i> = 57)</td><td>Solid Foods with Formula Feeding (<i>n</i> = 23)</td></tr><tr><td>Mean &#177; SD</td><td>Mean &#177; SD</td><td>Mean &#177; SD</td><td>Mean &#177; SD</td></tr><tr><td colspan="5">Weight (kg)</td></tr><tr><td>At birth</td><td>3.8 &#177; 0.4</td><td>3.8 &#177; 0.4</td><td>3.7 &#177; 0.4</td><td>3.7 &#177; 0.3</td></tr><tr><td>2 months</td><td>5.6 &#177; 0.6</td><td>5.5 &#177; 0.7</td><td>5.8 &#177; 0.5</td><td>5.4 &#177; 0.4</td></tr><tr><td>6 months</td><td>7.8 &#177; 0.8</td><td>8.2 &#177; 1.0</td><td>8.2 &#177; 1.0</td><td>8.5 &#177; 0.8 *</td></tr><tr><td>2 months</td><td>9.6 &#177; 0.9</td><td>10.3 &#177; 1.4</td><td>10.1 &#177; 1.2 *</td><td>10.6 &#177; 1.0 *</td></tr><tr><td>18 months</td><td>11.3 &#177; 1.0</td><td>11.5 &#177; 1.2</td><td>11.6 &#177; 1.3</td><td>11.9 &#177; 1.2 *</td></tr><tr><td colspan="5">Length (cm)</td></tr><tr><td>At birth</td><td>51.9 &#177; 1.5</td><td>52.0 &#177; 1.7</td><td>51.8 &#177; 1.6</td><td>51.7 &#177; 1.9</td></tr><tr><td>2 months</td><td>59.7 &#177; 1.5</td><td>59.4 &#177; 1.8</td><td>59.8 &#177; 2.0</td><td>58.9 &#177; 1.5</td></tr><tr><td>6 months</td><td>68.3 &#177; 2.0</td><td>69.4 &#177; 2.7</td><td>69.1 &#177; 2.3 *</td><td>68.4 &#177; 1.7</td></tr><tr><td>12 months</td><td>76.2 &#177; 2.5</td><td>77.4 &#177; 2.9</td><td>77.1 &#177; 2.7</td><td>77.6 &#177; 2.5 *</td></tr><tr><td>18 months</td><td>83.0 &#177; 2.5</td><td>83.8 &#177; 3.2</td><td>83.9 &#177; 2.7</td><td>83.1 &#177; 2.5</td></tr></table>
20a2b911780b64213361e46c1338e20fad4953eee37d1e399ebb186e672a24d5.png
simple
<table><tr><td></td><td>NSCLC cases (n = 34)</td><td>Controls (n = 30)</td><td>P-value</td></tr><tr><td>Age</td><td>67.56 (SD 11.12)</td><td>64.48 (SD 11.25)</td><td>0.33</td></tr><tr><td>Sex</td><td></td><td></td><td>0.35</td></tr><tr><td> Female</td><td>10</td><td>9</td><td></td></tr><tr><td> Male</td><td>24</td><td>21</td><td></td></tr><tr><td>Race</td><td></td><td></td><td>0.39</td></tr><tr><td> White</td><td>22</td><td>20</td><td></td></tr><tr><td> African American</td><td>11</td><td>10</td><td></td></tr><tr><td> Pack-years (median)</td><td>34.28</td><td>31.36</td><td>0.32</td></tr><tr><td>Stage</td><td></td><td></td><td></td></tr><tr><td> Stage I</td><td>10</td><td></td><td></td></tr><tr><td> Stage II</td><td>9</td><td></td><td></td></tr><tr><td> Stage III-IV</td><td>15</td><td></td><td></td></tr><tr><td>Histological type</td><td></td><td></td><td></td></tr><tr><td> Adenocarcinoma</td><td>21</td><td></td><td></td></tr><tr><td> Squamous cell carcinoma</td><td>13</td><td></td><td></td></tr></table>
9cf6cf9f46ce62655716c0631cbcf66a33e9dd40c63b688ab3fddb77240f3df7.png
simple
<table><tr><td>Percentile threshold</td><td>Number of ET SNPs</td><td>Number of ET genes</td><td>Number of diseases appropriately distributed among ET populations</td><td>Number of ET genes associated with appropriately distributed diseases</td><td>Permutation <i>P</i> value</td></tr><tr><td>95th/5th</td><td>22</td><td>33</td><td>6</td><td>4</td><td>0.0237</td></tr><tr><td>90th/10th</td><td>168</td><td>230</td><td>27</td><td>15</td><td>0.0111</td></tr><tr><td>85th/15th</td><td>733</td><td>971</td><td>42</td><td>49</td><td>0.0023</td></tr></table>